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Cowpox virus has been found to encode the inflammation modulatory protein (IMP) 
(Miller, e.G., 1997), a homologue of vaccinia virus complement control protein (VCP). 
VCP belongs to the regulation of complement activation (RCA) protein superfamily. It 
has been shown to inhibit both the alternative and classical pathways of complement 
activation by binding to the proteins C3 and C4, thereby preventing complement-
mediated opsonisation of virus, antibody-mediated lysis of infected cells and migration 
of inflammatory cells into the site of infection. VCP also possesses heparin binding 
sites. 
VCP and IMP were shown to have 92% amino acid sequence identity. The structure of 
VCP has been elucidated and was used to produce a model of IMP. The IMP model 
was found to be very similar to VCP, with only a few changes in hydrogen bonding. 
A deletion mutant of cowpox virus, lacking IMP (CPV IMP-) has been generated 
(Miller, e.G., et aI, 1997). CPV IMP- and the wild type cowpox virus (CPV WT) were 
cultured on the chick chorioallantoic membranes. The deletion of IMP in CPV IMP-
was confirmed by PCR. CPV WT and CPV IMP- were compared with respect to pock 
morphology on chick chorioallantoic membranes (CAMs) and plaque morphology on 
CV -1 mono layers. The 2 viruses were found to be indistinguishable with respect to 
size and appearance of both pocks and plaques. 
The growth of CPV IMP- was compared to that of CPV WT in cell culture and on the 
chick chorioallantoic membrane. Growth curves were generated for both viruses using 
2 different multiplicities of infection. The growth rates of CPV WT and CPV IMP- in 
cell culture and on the chick membranes were found to be statistically similar. 
A mouse model was used to investigate the role of IMP in vivo. Unfortunately, virus 
could not be detected by plaque assay. However, viral DNA was detected by PCR both 

















and so no conclusions could be drawn with respect to the effect of IMP on the 
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to each other at each end of the genome (Garon, C.F., et ai, 1978). The ITRs 
contain a hairpin loop which is purine-rich (Baroudy, B.M., et ai, 1982), sets of 
short tandem repeats (Wittek, R. and Moss, B., 1980), ORFs, and a short 
conserved region (DeLange, A.M. and McFadden, G., 1987; Merchlinsky, M., 
1990). 
Phylogenetic analysis of chordopoxviral genomes has been performed (Gubser, C. 
et ai, 2004; McLysaght, A., 2003). This has shown that the central 100 kb of 
DNA is highly conserved amongst all of the chordopoxviruses (except for gene 
inversions and insertions in Avipoxvirus and Molluscipoxvirus, respectively) 
(Gubser, C., et ai, 2004). Within this 100 kb of DNA, 90 genes are conserved. In 
addition to the high level of conservation seen, the order and spacing of these 
genes is also highly conserved (McLysaght, A., et ai, 2003). 
On the other hand, the terminal regions of the chordopoxviral genomes are highly 
divergent, and this divergence is seen even amongst different strains of the same 
species (Gubser, c., et ai, 2004). 
In spite of this conservation of DNA sequence, there is variation in the length of 
the chordopoxviral genomes (139 kb in Orfvirus [Delhon, G., et ai, 2004] to 365 
kb in canary pox virus [Tulman, E.R., et ai, 2004]), as well as in the A+T (adenine 
+ thymine) content (36% in Para poxvirus to 75% in Capripoxvirus). 
Phylogenetic analysis splits the Chordopoxvirinae into four groups (Gubser, C, et 
ai, 2004). The first group consists entirely ofthe Molluscipoxvirus genus, and the 
second group of the Avipoxvirus genus. Molluscipoxviruses and A vipoxviruses 
have diverged from the other chordopoxviruses a long time ago, and strictly infect 
only humans or birds, respectively. Thus, they have evolved unique 
countermeasures to deal with the immune systems of their hosts. The third and 
largest group consists of the Yatapoxvirus, Capripoxvirus, Sui poxvirus and 
Leporipoxvirus genera. The fourth group consists solely of the Orthopoxvirus 
genus. This group has diverged most recently, as the members in this group show 
greater similarity to each other than members within other groups do to each other 













Within the orthopoxviral group, variola virus (V AR) and camelpox virus (CMPV) 
group most closely together, and within the central conserved DNA region, these 
two genomes differ in length by only 82 nucleotides. Cowpox virus (CPV) 
Brighton strain, monkeypox virus (MPV) and ectromelia virus (ECTV) do not 
show close grouping with any of the other orthopoxviruses. VV groups closely to 
CPV GRI-90 strain. 
Interestingly, the two strains of CPV analyzed by Gubser, et al (2004), Brighton 
and GRI-90, did not group closely together at all, which indicates that perhaps 
they should be reclassified as two separate Orthopoxvirus species. In addition, 
Shchelkunov, S.N., et ai, (1998), suggest that CPV is the common ancestor virus 
for all orthopoxviruses, as the terminal region of its genome is intact, compared to 
other orthopoxviruses that have fragmented genes in this region. Both the 
Brighton and GRI-90 strains have these "complete" terminal genome regions, so 
both are candidates for the ancestral orthopoxvirus. 
The notion of CPV being the ancestral strain of orthopoxviruses is reiterated by 
the fact that of the complement protein 4 (C4) binding proteins, the inflammation 
modulatory protein (IMP) of CPV is the oldest of the homologues among the 
orthopoxviruses, by studies of the evolutionary relationships between the different 
complement-binding proteins and human C4b binding protein (Howard, J., et ai, 
1998). Indeed, it may be considered to be the ancestor of the VV and V AR 
homologues (Kotwal, GJ., 1997). 
There are a large number of genes occurring uniquely in the genomes of particular 
Chordopoxviruses and not in others. This indicates that evolution of poxvirus 
genome content has occurred and that poxviruses are continuously evolving 
independently of each other. Furthermore, analysis done by McLysaght et al 
(2003) show that both gene loss and gene gain have occurred during poxviral 
evolution, and that most of the gain of genes occurs by horizontal transfer events. 
Hughes and Friedman (2005) report that genes obtained by horizontal transfer are 
derived from the host and that this "stealing" of genes is fundamental to the 












2. The orthopoxvirallifecycle 
The life cycle of VV, the prototypal orthopoxvirus has been elucidated. It is 
extensively reviewed by Moss, B. (2001). It begins when VV virions attach to the 
cell membrane, penetrating it (Chang, A. and Metz, D.H., 1976; Doms, R.W., et 
ai, 1990). The virion core is released, which includes the double stranded DNA 
genome, enzymes and transcription factors. The early messenger ribonucleic acid 
(mRNA) molecules are synthesized within the core and then translated into 
various proteins, such as growth factors, immune defense molecules, enzymes, 
DNA replication factors and intermediate transcription factors (Sans, P. and 
Moss, B., 1999; Sanz, P. and Moss, B., 1998; Harris, N., et ai, ]993; Vos, J.C., et 
al,1991). 
Following translation of the early mRNAs, uncoating of the core occurs, followed 
by replication of the released DNA. The intermediate genes are then transcribed 
form the DNA in the cytoplasm and the mRNAs are translated. The proteins 
synthesized here are late transcription factors (McCraith, S., et ai, 2000; Wright, 
C.F., et ai, 199]; Keck, lG., et ai, 1993a; Keck, J.G., et ai, 1993b; Wright, C.F. 
and Coroneos, A.M., 1993; Hubbs, A.E. and Wright, C.F., 1996; Passarelli, A.L., 
et ai, 1996; Kovacs, G.R. and Moss, B., 1996). Next, the transcription of late 
genes and the translation of the mRNAs occur. The proteins synthesized here are 
virion structural proteins, enzymes and early transcription factors (Broyles, S.S., 
et ai, 1991; Broyles, S.S. and Moss, B., 1988; Broyles, S.S., et ai, 1988; Broyles, 
S.S and Fesler, B.S., 1990; Broyles, S.S. and Li, J, 1993; Gershon, P.D. and 
Moss, B., 1990; Li, l, et ai, 1994; Ahn, B. Y., et ai, 1994; Ahn, B. Y. and Moss, 
B., 1992). 
The membrane structures are then assembled and the DNA is packaged into 
immature virions (Hollinshead, M., et ai, ] 999; Salmons, T., et ai, 1997; Sodeik, 
B., et ai, 1993; Rodriguez, J.R., et ai, 1997; Wolffe, EJ., et ai, 1996; Rodriguez, 
J.R., et ai, 1998; Traktman, P., et ai, 2000). The immature virions then mature to 
form infectious intracellular mature virions. These virions are wrapped by Golgi 
membranes and moved to the cell periphery. Actin tails are attached to each 


















membrane and the extracellular enveloped virion is released from the cell (Moss, 
B., 2001). 
3. Interaction between poxviruses and the innate immune response 
Poxvirus infections result in either a localized infection, where there is a benign, 
self-limiting skin lesion e.g., infection with molluscum contagiosum (MCV) and 
Shope fibroma virus (SFV), or a systemic infection, where there is viral 
dissemination and possibly death e.g. infection of mice with ECTV and humans 
with VAR. 
The innate immune response plays an important role in combating poxvirus 
infections before an acquired immune response can be successfully mounted. In 
order to counteract this response the viruses encode a number of proteins which 
interact with the innate immune response. For example, this was shown by 
Froggatt, G.C., et al (2007), when the product of the vaccinia virus F3L gene was 
shown to down regulate the number of natural killer (NK) cells at the site of 
infection. The absence ofthis protein allows the NK cells to quicken the immune 
response to infection. 
Many different arms of the immune system are activated during poxvirus 
infection. In addition, there are many examples of poxvirus encoded homologues 
of immune proteins. These proteins are thought to have been acquired by the 
virus from the host during the co-evolution of the two species (Hughes, A.L. and 
Friedman, R., 2005). Thus, there is a fair amount of interplay between the host 
immune response and these viral encoded proteins, and this interplay determines 
to a large extent the outcome of disease in the infected host. 
For example, Interleukin (IL)-12 and IL-18 have been shown to act in synergy, 
activating NK cells and upregulating CD8+ T cells and Th1 activated immune 
responses against vaccinia virus (Gherardi, M.M., et ai, 2003). Bowie, A., et al 
(2000) have shown that the A52R gene product of vaccinia virus blocks activation 
of nuclear factor (NF) KB by more than one toll-like receptor, by disrupting 
















homology to the toll-like-IL-l-resistance domains (Stack, J., et ai, 2005), and is 
able to inhibit the signalling pathways that are toll-like receptor (TLR)-dependant. 
The TLRs are able to recognize pathogen molecular patterns that are conserved 
and in this way bring about recognition of particular pathogens (Medzhitov, R., et 
ai, 1997; Zarember, K.A. and Godowski, PJ., 2002). Thus, interference of this 
system allows the virus to avoid the antiviral action of the TLRs. 
Sakala, I.G., et al (2007) investigated the role of the ECTV interferon (INF)-y 
binding protein, and found that it was necessary to evade the development of a 
successful host immune response in mice. Furthermore, NK cells were found to . 
be vital for mouse survival and control of viral replication following infection 
with ECTV (Parker, A.K., et ai, 2007). Thus, though the immune system is able 
to mount a response to a poxvirus infection, many poxviruses have evolved to 
counteract very specific aspects of the immune system. Table 1 gives a few more 
examples of these proteins and the host function that the proteins inhibit. 
MCV, ECTV, VV and CPV all encode proteins which, although they have no 
sequence simi1arity to IL-18 receptors, are able to inhibit IL-18 activity (Smith, 
V.P., et aI, 2000). IL-18 is pro-inflammatory, activates NK cells, and induces the 
T -helper 1 response and the production of IFN-y. The viral-encoded IL-J8 
binding proteins would bind endogenous IL-18, thus dampening the effects of this 
interleukin. 
In addition to encoding virokines, poxviruses also encode viroreceptors. These 
are a subset of virokines and homologs of receptors of cytokines. For example, 
viral homologs of tumour necrosis factor receptor (TNFR) are encoded by 
myxoma virus, VV, CPV and SFV (Shchelkunov, S.N., et ai, 1993; Upton, C., et 
ai, ] 991). Tumour necrosis factor (TNF) is pro-inflammatory and activates many 
processes in the immune system (Fiers, W., ]991). The large amounts of viral 























Table 1: Table showing examples of immune evasion proteins encoded by 
poxvlruses an dh' III Ii t elr ce u ar unctIOns 
Poxvirus Pox protein Cellular function Reference 
MCV lL-18BP Binds IL-18 which: Smith, V.P., et ai, 2000 
ECTV Is pro-inflammatory; activates Viac, J. and Chardonnay, Y., 
VV NK cells; induces T-helper 1 1990 
CPV response; induces IFN-y 
Myxoma virus TNFR Binds TNF which: Shchelkunov, S.N., et aI, 1993 
VV Is pro-inflammatory; activates 
CPV many immune system 
SFV processes 
VAR lFN-yBP Binds IFN-y which: Shchelkunov, S.N., et aI, 1993 
VV Inhibits viral replication; Mossman, K., et aI, 1995 
CPV prevents lysis of infected cells; Alcami, A. and Smith, G.L., 
CMPV protects surrounding cells 1995 
from infection 
VV lL-]BP Binds IL-l which stimulates Spriggs, M.K., et aI, 1992 
CPV lymphocytes AJcami, A. and Smith, G.L., 
1992 
Orfvirus lL-lO Inhibits production of lFN-y, Haig, D.M., 1998 
lL-l, IL-6, and TNF-o::. : 
Important in B cell activation. 
VV 35 kDa binding Binds CC chemokines I Patel, A.H., et aI, 1990 
aI, I SFV protein Martinez-Pomares; L., et 
CPV .1995 
VAR Smith, C.A., et aI, 1997 
Alcami, A., et aI, 1998 
VV EGF-Iike proteins Promotes cell growth and Blomquist, M.C., et aI, 1984 
Myxoma virus differentiation Brown, J.P., et aI, 1985 
SFV Chang, W., et aI, 1990 
VAR, VV, CPV and CMPV encode INF-y receptor homologs (Shchelkunov, 
S.N., et aI, 1993; Mossman, K., et ai, 1995; A1cami, A. and Smith, G.L., 1995). 
This viral receptor binds INF-y, thus blocking its effects (which are to protect 
surrounding cells from infection, inhibit viral replication and prevent lysis of the 
infected cell (Farrar, M.A. and Schreiber, R.D., 1993)). VV and CPV also encode 
an IL-l binding protein (Spriggs, M.K., et aI, 1992; A1cami, A. and Smith, G.L., 
1992). Binding of endogenous IL-l by viral IL-l receptor inhibits the stimulation 
of lymphocytes by IL-l (Dinarello, c.A., 1989). 
The MCV proteins mc053R and mc054R share homology with the host IL-18/IL-
In receptor (Viae, J. and Chardonnet, Y., 1990). Orfvirus produces a homolog of 
IL-IO, which is most closely related to the IL 1 0 of sheep, its host. The orfIL-I0 
may playa role in orf viral replication (Haig, D.M., 1998). VV, SFV, CPV and 
V AR all encode a 35 kDa (Patel, A.H., et ai, 1990; Martinez-Pomares, L., et ai, 











(Smith, C.A., et ai, 1997; AIcami, A., et ai, 1998). The vaccinia virus C II R gene 
product is a protein that shares sequence identity with epidermal growth factor 
(EGF) and transforming growth factor-a (TGFa) (Blomquist, M.C., et ai, 1984; 
Brown, J.P., et ai, 1985). It competes for binding to the EGF receptor with EGF. 
It is also a strong mitogen (Stroobant, P., et ai, 1985; King, C.S., et ai, 1986). 
In this review, however, only the complement system will be given attention in 
detail, since the focus of the project is on a CPV protein postulated to mimic the 
complement control proteins. 
4. The complement system 
The complement system consists of more than 30 proteins that form a proteolytic 
cascade system. The complement system operates in an exact sequence to 
eliminate invading micro-organisms from the body. Once the complement 
cascade is initiated, proteins in the pathway are activated sequentially. Activation 
of each successive protein occurs by the cleavage and/or association of two or 
more proteins that are activated at earlier stages in the cascade. 
There are three pathways whereby the complement system can be activated: the 
classical pathway (MUller-Eberhard, H.J. et ai, 1967), the alternative pathway 
(Gotze and MUlier-Eberhard, ] 97]; Marcus et aI, ] 97]), and the mannan-binding 
lectin (MBL) pathway (Thiel, S., 1997). The proteins in the three pathways share 
structural and functional homology, and the same end-product is produced by 
them (namely, the membrane attack complex [MAC]). Complement protein 3 
(C3) is central to each pathway. However, activation of the different pathways 
occurs by different mechanisms. The classical pathway is triggered by binding of 
antibody (Immunoglobulin (Ig) M or IgG) to foreign antigen, whereas in the 
alternative pathway there is continuous degradation of C3 (Pangburn, M.K. and 
MUller-Eberhard, H.J., 1980; Pangburn, M.K., et ai, ] 981) allowing for activation 
when there is a pathogen or infected cell in the vicinity. The mannan-binding 
lectin pathway is activated when C3 is in complex with MBL associated serine 
protease (MASP)-I, -2 and- 3, and binds to carbohydrates, especially mannose, on 
the surface of microbial or virus-infected host cells (Lee, S-H, et ai, 2003; 
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Favoreel, H. W., et ai, 2003). Figure 1 shows an overview of the complement 
cascade. 
Following activation of the complement system, C3 is continuously cleaved to 
yield the products C3a and C3b. The enzymes catalyzing this reaction are called 
C3 convertases. C3b binds to the protein Bb, which is generated by the enzymatic 
cleavage of Factor B. This new protein, C3bBb, catalyzes the breakdown of still 
more C3 to C3a and C3b, and thus it is the alternative pathway C3 convertase. 
Classical pathway 
Antibody binds to antigen 
Mannan-binding lectin pathway 
M8L binds to pathogen 
Alternative Pathway 
Constant spontaneous 
breakdown of C3 in 
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Fig. 1: Flow diagram outlining the sequence of events in the classical, 
alternative and MBL pathways of complement activation, leading to the 
formation of the MAC. Green arrows indicate enzymatic cleavage. 
C3a 
The classical pathway C3 convertase is the protein C4b2a, formed by the binding 
of complement proteins C4b and C2a. It forms in the following way: antigen-
bound antibodies bind to the complement protein C I. This C I-anti body-antigen 
complex then catalyzes the cleavage of C4 and C2 into C4b and C2a, 











The C3b produced through the enzymatic cleavage of C3 by the C3 convertases 
has one of two fates. Firstly, the C3b can attach to the surface of pathogens or 
pathogen infected cells, acting as opsonins. Complement receptor 1 (CRl), which 
is expressed in the membranes of macrophages' and polymorphonuclear 
leukocytes, then binds to this C3b, activating the phagocytosis of the C3b-coated 
pathogen/infected cell (Parham, P., 2005). This opsonisation is one of the main 
goals of the complement system. 
Secondly, the C3b produced can form a complex with the C3 convertases to form 
the C5 convertases. (Alternative pathway C5convertase: C3bBb3b; classical 
pathway C5 convertase: C4b2a3b). Both convertases, although distinct enzymes, 
catalyze the cleavage of C5 into C5a and C5b. 
Once C5b is formed, C6 and C7 bind to it to form the C5b67 complex, which then 
binds to a cell membrane (e.g. that of a virus-infected cell). C8 and C9 then join 
the membrane-bound complex to form C5b6789, the MAC (Parham, P., 2005). 
The MAC functions to insert into the membranes of infected cells, forming pores 
and this results in lysis of the cell (Kolb, W.P. and Milller-Eberhard, H.J., 1973). 
This is the second function of the complement system: to lyse and thus kill 
pathogen-infected cells, resulting in the destruction of the pathogen as well. 
C3a, C4a and C5a are small chemoattractant peptides produced during the 
activation of the complement system that are anaphylatoxins (Parham, P., 2005). 
They bind to receptors on mast cells and basophils, resulting in the release of 
vasoactive compounds, such as histamine, causing increased blood flow and 
permeability in the region of infection (HugJi, T.E., 1984, Structure and function 
of the anaphylatoxins, Springer Seminars in Immunopathology, 7: 193-220; taken 
from Tosi, M.F., 2005). In doing so, these peptides implicate the complement 
system in the inflammatory response. In addition, C5a attracts monocytes and 
neutrophils to the site of infection by acting as a chemoattractant. This is the third 
function of the complement system: to increase blood flow and influx of immune 















4.1. Complement control proteins 
Control of the complement system centres on the C3 convertase of the classical 
and MBL pathways (C4b2a) and that of the alternative pathway (C3bBb). This is 
not surprising, since the C3 convertases form the central point of the complement 
cascade. Two plasma proteins involved in C3 convertase regulation are C4b 
binding protein (C4BP) and factor H (fl-I) (Parham, P., 2005). C4BP binds to the 
C4b moiety of C4b2a, making the convertase vulnerable to cleavage by factor I 
(fl). fH binds to the C3b moiety of C3bBb, also making it vulnerable to cleavage 
by fl. This binding of C4BP and fH to the C3 convertase in order to facilitate its 
cleavage by another protein is known as cofactor activity. 
Two membrane-bound proteins involved in complement regulation are decay 
acceleration factor (DAF) and membrane cofactor protein (MCP) (Parham, P., 
2005). DAF binds to both the C4b and C3b moieties of the c1assicallMBL and 
alternative pathways, respectively, causing their dissociation from the 2a and Bb 
moieties. In this way the convertase is inactivated. This activity of DAF is 
known as decay acceleration. MCP also bind to C4b and C3b, resulting in 
dissociation of the convertase. However, by binding to the convertase MCP also 
makes it vulnerable to cleavage by fl. Thus MCP has both decay acceleration 
activity and cofactor activity. 
These regulatory proteins all belong to the regulators of complement activation 
(RCA) family. All contain between 2 and 30 copies of repeat unit, known as a 
short consensus repeat (SCR) or a complement control protein module. Each 
SCR is made up of roughly 60 amino acids, with a consensus sequence of four 
cysteine residues, in which residues 1 and 3, and 2 and 4, are linked by disulphide 
bonds. In addition, a tryptophan residue is situated between residues 3 and 4 
(Herbert, A., et aI, 2002). 
5. Complement control proteins encoded by poxviruses 
Since the complement system forms part of defence against viral infections, it is 















proteolytic cascade. Many viruses have been found to encode complement 
control protein (CCP) homoJogues. These too form part of the RCA family. 
One viral genus with multiple species encoding CCP homologues is 
Orthopoxvirus. In fact, the first CCP homologue to be discovered was that of 
VV, called vaccinia virus complement control protein (VCP) (Kotwal, GJ., and 
Moss, B., 1988). Other orthopoxviruses with CCPs are V AR, which encodes the 
smallpox inhibitor of complement enzymes (SPICE) (Massung, R.F., et ai, 1996), 
CPV, encoding IMP (Miller, e.G., et ai, 1997) and MPV, encoding the 
monkeypox inhibitor of complement enzymes (MOPICE) (Chen, N., et ai, 2005). 
VCP has greatest homology to C4BP (Kotwal, G.J. and Moss, B, 1988), and in 
binding C4b it causes accelerated decay of the classical pathway C3 convertase 
(Miller, e.G., et ai, 1997). It is also able to bind to C3b, causing decay 
acceleration of the alternative pathway C3 convertase (McKenzie, R., et ai, 1992) 
(see fig. 1). As a result of this decay acceleration, the complement system is 
inhibited. Opsonization of the infected cell does not occur; the membrane attack 
complex is not formed and thus lysis of the infected cell is avoided; and 
inflammation does not occur in the infected region of the body. All this means 
that VV is able to regulate its environment, making it a favourable one for 
infection and replication. 
The role VCP plays in downregulating the complement system is thought to be of 
potential therapeutic use. There are certain pathophysiological processes in which 
the resulting damage is due to the consequences of activating the complement 
system. Examples of these are spinal cord injury and ischaemia-reperfusion 
injury (Fleming, S.D., et ai, 2003), as well as in the diseases Alzheimer's (Tuppo, 
E.E. and Arias, H.R., 2005) and multiple sclerosis (Tran, G.T., et ai, 2002). 
All of these poxviral CCPs consist of four RCAs, with the exception of MOPICE 
which has a truncated fourth CCP, and also a single base deletion that results in a 
premature stop codon in the fourth CCP (Uvarova, E.A. and Shchelkunov, S.N., 
2001). Furthermore, the poxviral proteins all share more than 90% sequence 
identity with each other and approximately 35% identity with their human 


















Each poxviral protein is derived from its particular host homolog (Shchelkunov, 
S.N., et ai, 1996). For example, SPICE is derived from the human protein C4bp, 
and thus it is more specific for human C4b than is VCP (Rosengard, A.M., et ai, 
2002). The proteins act as virulence factors. There are two strains of MPV, the 
Congo Basin strain, encoding an intact MOPICE, and the West Africa strain, 
which lacks MOPICE. The West African strain is less virulent, whereas the 
Congo Basin strain is virulent (Chen, N., et ai, 2005). Human-to-human 
transmission has also been described for the Congo Basin strain and this strain has 
a fatality rate of 4-25% (Hutin, Y.J.F., et ai, 2001). It is not known whether 
MOPICE contributes directly to the virulence of the Congo Basin strain or not, 
however one could speculate that it does. VCP prevents antibody-dependent 
complement-enhanced neutralization of vaccinia virus, and in addition rabbits 
inoculated with a VCP-knockout virus caused skin lesions that were smaller in 
size than those seen in animals infected with wild type virus (Isaacs, S.N., et ai, 
1992). 
6. Cowpox virus 
Cowpox virus is thought to be the most likely ancestor of all the other 
orthopoxviruses (Shchelkunov, S.N. et ai, 1998). This is due to the fact that it has 
a somewhat "complete" genome, whereas the other genera of orthopoxvirus have 
a larger number of fragmented genes whose cowpox virus counterparts are intact. 
The CPV has been sequenced and deposited in Genbank (AF482758). 
Cowpox virus has been isolated in western Eurasia, with Norway, Northern 
Russia, Turkmenia, Northern Italy, France and Great Britain forming the 
boundary around the region (Baxby, D., et ai, 1994). Despite its name, cows are 
not the natural reservoir for CPV, and Chan trey et al (1999) have shown that the 
natural reservoir in Great Britain is both the bank and field vole. These two 
species are also endemic in the geographic range of CPV. In addition, other 
rodents may act as reservoirs, such as suslicks, gerbils and wood mice, but it is 
likely that these species of rodent need the virus to be re-introduced from time to 











CPV infection in humans represents a zoonosis, and more often than not the 
source of virus infection is the domestic cat (Baxby, D., et ai, 1994). Acquisition 
of virus occurs when the virus comes into contact with broken skin. Lesions are 
found most commonly on the fingers and hands, and also on the face of infected 
individuals. 
Cowpox virus has an array of proteins which allow it to actively evade attack 
from the immune system. These will be discussed individually below. 
• Cytokine response modifier A (CrmA) (pickup, DJ., et ai, 1986) was first 
predicted to be an inhibitor of one or more of the serine proteases involved in 
the blood coagulation cascade. Later it was shown to bind the IL-l ~ converting 
enzyme (Ray et ai, 1992), thus blocking the effects of IL-l~, a pro-
inflammatory cytokine. Other cytokine response modifiers include CrmB (Hu, 
F.-Q., et ai, 1994); CrmC (Smith, C.A., et ai, 1996); CrmD (Loparev, V.N., et 
ai, 1998); and CrmE (Saraiva, M. and Alcami, A., 2001). CrmB, CrmC, CrmD 
and CrmE all have the ability to bind TNF. Thus they are TNFR homologues. 
They differ in size, time of production post-infection, and also in their binding 
specificity for TNF. For example, CrmB is expressed early in infection and 
binds both TNFa and TNF~. CrmC is expressed late and only binds TNFa. 
CrmD is also expressed late, but like CrmB, binds TNFa and TNF~. CrmE 
binds only TNFa. Thus cowpox virus is able to modulate the cytokine response 
at practically all times post-infection. CrmA has also been found to inhibit 
apoptosis in infected cells (Tewari, M. and Dixit, V.M., 1995) 
• An IFN-y-binding protein (Mossman, K., et ai, 1995; Alcami, A. and Smith, 
G.L., 1995) of CPV displays a wide range of species specificity. It can bind 
human, bovine and rat IFN-y, which is a critical antiviral component of the 
immune system. This is indicative of the wide host range displayed by the 
virus. It may also be an indication of the different species used by the virus as a 
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• CPV expresses an IL-18 binding protein (Smith, V.P., et ai, 2000). IL-18 is 
also involved in inducing an antiviral state and thus secretion of a protein that 
binds it would be advantageous to CPV. It is notable that the viral IL-18 
binding protein does not have homology to the host IL-18 receptor (Smith, V.P., 
et ai, 2000). 
• A chemokine binding protein (Smith, e.A., et ai, 1997; Graham, K.A., et ai, 
1997) binds pro inflammatory chemokines and acts as a competitive inhibitor of 
chemokine receptors. Like the IL-18 binding protein encoded by CPV, this 
chemokine binding protein also does not show sequence homology to known 
host chemokine receptors (Graham, K.A., et ai, 1997). 
• An IL-l binding protein (Spriggs, M.K., et ai, 1992) binds IL-l~. Thus, CPV 
encodes two proteins which are structurally unrelated yet have the same 
function, Le. to inhibit the effects of host-derived IL-J~. These are CrmA, 
which binds IL-l~ converting enzyme, and the viral IL-l~ binding protein, 
which binds IL-l~. 
• An as yet unidentified protein which allows the virus to bypass identification by 
CPV-specific T cells (Dasgupta, A., et ai, 2007) is encoded by CPV. This is 
though to be mediated by interference with the major histocompatibility 
complex (MHC) processing and transport within the infected cell, thus 
preventing MHC I antigen presentation. Furthermore, CPV has been shown to 
inhibit expression of genes under the regulation ofNF-KB, interfere with NF-KB 
activation, and to disrupt processes leading to the degradation of IKBo: (Oie, 
K.L. and Pickup, DJ., 2001) 
• CPV complement control protein (Miller, C.G., et aI, 1997) will be discussed in 
more detail below. 
The CPV IMP is a homologue ofVCP (Miller, e.G., et ai, 1997). Previous work 
has also shown that CPV is able to regulate its habitat via C5 (Miller, C.G., et ai, 


















C5-sufficient mice following injection in the footpads with CPV. Also, 
reinfection in the footpads following complete recovery elicited only slight 
swelling, indicating that the secondary response to infection is not regulated by 
the complement system. 
Studies in C3-sufficient and C3-deficient mice indicated that the IMP also 
interacts with C3 (Kotwal, GJ., et aZ, 1998), since footpad infections elicited 
greater swelling responses in the C3-deficient mice than in C3-sufficient mice. 
Furthermore, swelling in C3-deficient mice injected with either CPV or CPV 
lacking IMP was relatively equal. 
A recombinant virus lacking IMP has been generated (Miller, C.G., et aZ, 1997). 
The aim of this project was to determine the effect of IMP on viral growth in 
vitro, in ovo and in an in vivo mammalian model. Although the role of VCP has 
been established in VV, the effect of VCP on viral growth has not been 
determined. I have compared the putative structure of CPV IMP to that of the 
known structure of VV VCP. To determine the effect of this complement 
modulating protein on growth, wild type and recombinant CPV were compared 
with respect to growth in cell culture, on chick chorioallantoic membranes 
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The complement modulatory protein sequences that have been analysed thus far 
include those for membrane cofactor protein (MCP) (Cervoni, F., at ai, 1993), 
C4b binding protein (C4BP) (Lintin, S.J., et ai, 1988), smallpox inhibitor of 
complement enzymes (SPICE) (Zhang, L. and Morikis, D., 2006) and vaccinia 
virus complement control protein (VCP) (Ganesh, V.K., et ai, 2004; Murthy, K., 
et ai, 2001). The sequence of the inflammation modulatory protein (IMP) of 
cowpox virus (CPV), a homolog of VCP, is also known, but to date its three-
dimensional structure has not been determined. 
The IMP ofCPV has 92% amino acid identity to VCP ofVV (Miller, C.G., et ai, 
1997). This high sequence similarity, together with the availability of crystal 
structures of VCP (Ganesh, V.K., et ai, 2004; Murthy, K., et ai, 2001), makes 
IMP a good candidate for homology modelling, since the accuracy of predicted 
protein structures increases with an increase in homology between the target and 
template sequences (www.expasy.org). 
To date, the only poxviral complement control protein structure available is that 
of VCP. Thus, the aim of this experiment was to generate a three-dimensional 
structure of IMP, based on the known structure of VCP, using computer 
modelling. 
The SWISS-MODEL server (Guex, N. and Peitsch, M.C., 1997; Arnold, K., et ai, 
2006; Kopp, J., and Schwede, T., 2006) is a tool for homology modelling. This 
server has three different modes, which can be used depending on the modelling 
requirements (Schwede, T., et ai, 2003): 
1. First approach mode this requires only the amino acid sequence of the 
protein to be modelled. Suitable templates are automatically chosen from 
the protein database by SWISS-MODEL. At least one template with more 
















2. Alignment interface mode a sequence alignment is submitted to the 
SWISS-MODEL server. The model of the target sequence is then built 
using the structure of the protein to which it is aligned. 
3. Project mode - in this mode a manually optimized model is submitted to 
the server. The model consists of superimposed structures as well as an 
alignment between the target amino acid sequence and the template 
sequences. Unlike the first two modes, in this one the user decides on the 
templates to be used, and in addition it can be used to improve the result of 
the first approach mode. 
The alignment interface mode is suitable for cases such as IMP, where a single 
template sequence has been identified. This mode was used to determine the 














2.2. Materials and Methods 
The amino acid sequences of IMP and VCP were obtained from 
www.ncbLnlm.nih.gov (accession numbers AAM13481 and P68638, 
respectively). The two sequences were aligned using DNA MAN version 4.0 
(Lynnon BioSoft). The alignment was submitted to the SWISS MODEL server at 
http://swissmodel.expasy.org in fasta format using the Alignment Interface mode. 
The protein structure ofVCP has already been determined (Ganesh, V.K., et ai, 
2005, Ganesh, V.K., et ai, 2004, and Murthy, K.H.M., et ai, 2001) and the 
structures are available the protein databank. The template structure used to 
generate the IMP protein model was that produced by Murthy, K.H.M., et ai, 
2001, (PBD ID 1 g40). The output structure was visualized and analyzed using 
Swiss-PdbViewer. The template and model coordinates were submitted to 
MolProbity (www.molprobity.biochem.duke.edu/; Davis, LW., et ai, 2004), a 
programme which calculates the Ramachandran plots for protein structures and 
identifies errors in stereochemistry. 
The template and model structures were then compared, using the following 
criteria: 
2.2.1. Amino acid differences between VCP and IMP. 
2.2.2. Analysis of amino acids important in binding complement components 
and cofactor activity. 
2.3.3. Intramolecular hydrogen bonding in VCP and IMP. The hydrogen bond 
detection threshold was set at 2.4 - 3.6 A. 
2.3.4. Comparison of Ramachandran plots for VCP and IMP. The co-ordinates 



















The amino acid sequence alignment of VCP and IMP (fig. 2.1) was submitted to 
the SWISS-MODEL server, using the alignment interface mode, and a homology 
model ofIMP based on VCP (PDB 10 1940) was obtained. 
Alignment of VCP Western Reserve(upper line) and IMP Brighton Red 
pr(lower line) 
Identity=93 % Similar residues=7% 
1 CCTIPSRPINM NSVETDANANYNIGDTIEYLCLPGYRIIIMGPIYAKCTGTGWTLFN 
I I I I I II I II I I I I I I I: II I II I I I I I I I I I II I II I I I I II I II I II I I I I I I I I I II 
1 CCTIPSRPINM NSVGTDANANYNIGDTIEYLCLPGYR GPIYAKCTGTGWTLFN 
61 QCI CPSPRDIDNGQLDIGGVDFGSSITYSCNSGYHLIGESKSYCELGSTGSMVWNPE 
I I I I I : I I I II I II I I I : I I II I: I I I I I I I I I I I I I: I I I I I I I I I I I I I I I I I I I I I 
61 QC I CPSPRDIDNGQIDIGGVEFGSSITYSCNSGYQLIGESKSYCELGYTGSMVWNPE 
121 APICESVKCQSPPSISNGRHNGYEDFYTDGSVVTYSCNSGYSLIGNSGVLCSGGEWSDPP 
I I I I I I I I I. I II I: . I I I I I I I III I I I I I I I I I I I I II I I I I I I I I: : I II I I I I I I I 
121 APICESVKCPSPPSVTNGRHNGYEDFYTDGSVVTYSCNSGYSLIGNSGIVCSGGEWSDPP 
181 TCQIVKCPHPTISNGYLSSGFKRSYSYNDNVDF YGYKLSGSSSSTCSPGNTWKPELP 
I I I I I I I I I I. I . II I I I I I I I I I I I I I I I I I I I: II I II I I I I I I I I I I I II. I I I I 
181 TCQIVKCPHPSITNGYLSSGFKRSYSHNDNVDF HGYKLSGSSSSTCSPGNTWQPELP 
241 KCVR 
I I I I 
241 KCVR 
Figure 2.1: Figure showing alignment of the amino acid sequences of VCP 
Western Reserve and IMP Brighton Red aligned. Amino acids shown in 
pink indicate the putative heparin binding sites. Vertical dashes indicate 
identical amino acids in the two proteins. The alignment was performed 
using the computer programme DNA MAN version 4.0. 
When the IMP homology molecule is shown in a ribbon diagram, (fig. 2.2), one 
can see which amino acid residues form part of secondary structure elements such 
as beta sheets. As with VCP, IMP is an elongated protein with four globular 
domains. Amino acid differences between VCP and IMP (green in fig. 2.2) are 










wnFig 2.2: Computed three-dimensional structure of IMP based on a VCP template structure from the protein data bank (lg40.pdb; Murthy, K.H.M., et ai, 2001), shown as a ribbon diagram (blue) with white line representation of the atomic 
structure. Amino acids shown in green are those that are mutated with respect to 
VCP. 
2.3.1. AMINO ACID DIFFERENCES BETWEEN VCP AND IMP IN 
BETA SHEETS 
Figure 2.1 shows the amino acid sequence alignment between VCP and IMP. 
Horizontal dashes indicate identical residues between the two sequences. As 
shown in figure 3, there are 17 amino acid differences in IMP with respect to the 
VCP sequence. The majority of these differences are not likely to result in any 
major changes i  protein conformation or function. VCP residues which are 
postulated to form points of contact with C3b are R7, K12, K14, R40, K41, K43, 
KSO, K64, R6S, R66, E 1 02, K 186 and H 189. In 1M P all these residues are 
conserved, except R66 which is substituted by K in IMP. However, this is the 
replacement of one positive residue with another, and so the positively charged 
patch formed by these residues at the junction between modules 1 and 2 would be 
conserved (Ganesh, V.K., et ai, 2004). Furthermore, residues postulated to 
contact C4b in VCP are N94, H98 and E 1 02. Tn IMP, residue 98 is Q, which is a 











amino acid (glutamine) in IMP. Two other differences occur in the beta sheets 
and these are Gln98, which is a His in YCP, and Gln236, which is a Lys in YCP. 
There are 4 potentially significant amino acid differences between YCP and IMP. 
Firstly, VCPE_18_GIMP is a change from a polar, charged amino acid (glutamate) to 
a non-polar, uncharged amino acid (glycine). Furthermore, glutamate has a high 
helix-forming propensity, whereas glycine does not promote helix formation, 
since it is highly flexible and thus it is energetically unfavourable for it to adopt 
the restrained alpha-helix conformation. 
VCPS_lll_ ylMP is a change from an amino acid with a short side chain that is 
inclined to interrupt alpha helices (serine), to one with an aromatic ring (tyrosine). 
In YCP, SIll forms part of module 2 and lies within a 5-residue insertion that 
forms a loop close to the interface between modules 1 and 2 (Murthy, K.H.M., et 
af,2001). 
VCPQ_130_pIMP is a change from a polar amino acid with a chain structure 
(glutamine) to a hydrophobic, cyclic amino acid (proline). Furthermore, proline is 
not usually found in a helices and has the propensity for forming 13 turns. 
VCPK_236_QIMP is a change from a long chain amino acid (lysine) to a short chain 
one (glutamine). 
2.3.2. ANALYSIS OF AMINO ACIDS IMPORTANT IN BINDING 
COMPLEMENT COMPONENTS AND COFACTOR ACTIVITY 
R7, K12, K14, R40, K41, K43, K50, K64, R65 and R66 are residues in the YCP 
molecule shown to be important in binding C3b and/or C4b (Murthy, K.H.M., et 
af, 2001). Except for R66 (a conservative change from arginine to lysine), all 
these residues are conserved in IMP. 
As mentioned previously, of particular importance in C4b binding are the residues 
94, 98 and 102 (Liszewski, M.K., et af, 2000; Murthy, K.H.M., et af, 2001). 











shows an alignment of IMP and YCP, with residue 98 highlighted In each 
molecule. This alignment was kindly provided by Prof. Krishna Murthy. In YCP 
this residue is histidine, while in IMP it is glutamine. 
The conservation of the heparin binding sites in IMP is also of biological 
importance. In YCP, binding of heparin results in a conformational change in the 
protein that changes the orientation of K186, H189, F201 and R203, relative to 
N94, H98, E I 02 and E I 08 (Ganesh, Y.K., et ai, 2004). This conformational 
change is thought to be important in YCP binding to C3b and C4b, because, with 
the exception of F20 I, the residues affected are thought to be points of contact 
between YCP and C3b or C4b. 
2.3.3. INTRAMOLECULAR HYDROGEN BONDING IN VCP AND 
IMP 
There are some changes regarding hydrogen bonding of residues that are mutated 
in IMP with respect to YCP (Table 2). However, the overall number of hydrogen 
bonds in the whole molecule is fairly similar in YCP and IMP. YCP has 144 
hydrogen bonds while IMP has 139. Hydrogen bonds play an important role in 
holding the molecule together. Here there is a 5 hydrogen bond difference 
between the two molecules. This suggests that IMP may be less stable than YCP. 
However, the intramolecular hydrogen bonds are formed between atoms in the 
side chains of the amino acids. In a model, the side chain atoms do not 
necessarily occupy the same positions in space as they do in reality. Thus, 
caution needs to be exercised when making predictions regarding protein structure 











Fig 2.3: Alignment of three-dimensional structures of VCP and IMP. VCP is shown 
in red and IMP is shown in blue. Residue 98 in each molecule is highlighted. In IMP 
this is a glutamine, shown in magenta, and in VCP it is a histidine, shown in yellow. 
Table 2: Table showing the amino acid residues at various positions in VCP and 
1M P, and the number of hydrogen bonds formed by each 
Residue VCP IMP 
Number Residue # H bonds Residue # H bonds 
18 E 2 G 0 
84 0 2 E 1 
1 11 S 3 Y 1 
130 Q 3 P 1 
135 I 0 V 2 
J 91 T 1 S 0 
207 Y 0 H 2 











2.3.4. Comparison of Ramachandran plots for VCP and IMP 
A Ramachandran plot is a two-dimensional plot of psi vs phi torsion angles of the 
protein backbone for each amino acid in a protein structure. Favoured regions of 
the plot have been determined by analysing databases of known protein structures 
of high quality (Struyer, L., 1995). 
The Ramachandran plots obtained are shown in figures 2.4 and 2.5. In a 
Ramachandran plot, it is preferable that most of the residues lie in favoured 
regions (98%) or at least allowed regions (>99.8%). For IMP (Fig. 2.4), 69.3% 
and 89.6% of the residues were found to be in favoured and allowed regions, 
respectively. For VCP (Fig. 2.5), 70.1 % and 88.8% were found to be in favoured 
and allowed regions, respectively. 
The percentage of residues found in allowed regions for IMP appears to be low. 
However, the template used (VCP) yielded a Ramachandran plot with an even 
lower percentage of residues in allowed regions. Thus this is probably the reason 
the low percentage for IMP was obtained and one could say that these two 
structures (VCP and IMP) are similar. 
Ramachandran plots were generated for the ly8e and Irid VCP templates. For 
ly8e, 73.1 % and 90.5% of residues were found in favoured and allowed regions, 
respectively. For 1 rid, 74.8% and 90.9% of residues were found in favoured and 
allowed regions, respectively. These values are slightly higher than those for the 
I g40 VCP template (70.) % and 88.8%). However, the resolutions for each 
template (2.1, 2.2 and 2.1 for 1 g40, ly8e and 1 rid, respectively) were close in 
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Figure 2.4: Ramachandran plot for IMP. Circles/squares that fall within the 
dark blue regions represent amino acids in allowed positions. Circles/squares 
that fall within the light blue regions represent amino acids in favoured 
regions. Purple circles represent amino acids in disallowed regions. 
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Figure 2.5: Ramachandran plot for YCP. Circles/squares that fall within the 
dark blue regions represent amino acids in allowed positions. Circles/squares 
that fall within the light blue regions represent amino acids in favoured 












The inflammation modulatory protein of CPV has 92% amino acid identity to the 
complement modulatory protein of VV, vaccinia virus complement control 
protein (VCP). The high level of homology suggests that these two proteins have 
analogous functions. Indeed, vaccinia virus VCP is the inflammation modulating 
protein homolog of IMP in VV. 
Extensive research has been done on the structure and function of VCP, as VV is 
the most studied orthopoxvirus. It has been found that VCP is able to bind 
heparin on the surface of human endothelial cells (Smith, S.A., et ai, 2000). This 
is analogous to the presence of heparin binding sites in fH and C4BP (Pangburn, 
M.K., et ai, 1991; Blackmore, T.K., et ai, 1998; Hessing, M., et ai, 1990). For 
fH, the ability to bind heparin is crucial in differentiating between complement 
activator surfaces and host cell surfaces (Pangburn, M.K., et ai, 2000) as the 
alternative pathway does not make use of antibodies to distinguish between target 
and host cells (Meri, S. and Pangburn, M.K., 1990). 
These heparin binding sites in VCP are conserved in IMP, as shown in figure 2B. 
Thus it would be expected that IMP retains the properties conferred on VCP 
through its heparin binding ability. These include binding to the surface of host 
cells, thus protecting them from complement mediated lysis; entry into mast cells, 
allowing for persistence in host tissue, thus contributing to preservation of the 
viral habitat (Smith, S.A., et ai, 2000); reduction of chemotactic migration of 
leukocytes to the site of infection (Smith, S.A., et ai, 2000); and the ability to 
prevent binding of antibodies to surface MHC class I molecules, by binding 
heparin-like molecules on the surface of endothelial cells (Smith, S.A., et ai, 
2000). 
Murthy, K.H.M., et ai, (2001) highlighted a few important regions within the 
VCP molecule. The first of these consist of the amino acid residues R7, K12, 
K 14, R40, K41, K43, K50, K64, R65, and R66. These residues are postulated to 
form points of contact between VCP and either C3b or C4b, thus accounting for 











All of these residues are conserved in IMP. Thus it retains the ability to bind C3b 
or C4b via this region. 
Liszewski, M.K., et al (2000) showed that in membrane cofactor protein (MCP), 
the principle cofactor for fl which binds both C3b and C4b, residues Y97, Y98, 
L99, and £ 103 are important in cofactor activity of C4b, while mutations of 
residues £95, G96 and E 102 decrease binding ofC4b and cofactor activity. 
In VCP, this stretch of residues is homologous to MCP, and Murthy, K.H.M., et 
ai, (2001) have shown that of particular importance are the residues 94, 98 and 
102. In VCP these are N94, H98 and E 102. However, in IMP there is a H98Q 
mutation, relative to YCP. While histidine is aromatic and positively charged, 
glutamine remains uncharged and polar. This may affect the binding affinity of 
IMP for C4b if the interaction between the proteins is an electrostatic one. SPICE 
is the homolog of VCP and IMP in variola virus (Massung, R.F., et ai, 1993) and 
analysis of its sequence shows that this residue is a tyrosine (Y98) (Rosengard, 
A.M., et ai, 2002), making it more similar to H98 of MCP, and therefore perhaps 
accounting for the greater efficiency of SPICE in C4b binding than VCP. The 
amino acid difference between IMP and SPICE at residue 98 most likely has 
implications in the efficiency of IMP in binding C4b. The natural host of CPV is 
the rodent. However, mouse C4b is 95% homologous to that of humans 
(Blangchong, CA., et ai, 2001). Thus one would expect that IMP is likely to 
have the ability to bind human C4b with as high efficiency as it binds mouse C4b. 
Overall, this experiment has shown that the computed putative structure of IMP is 
very similar to that of VCP. It is highly likely that the function of this protein is 
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The inflammation modulatory protein (IMP) of cowpox virus (CPY) is a 
complement control protein homolog, having greatest similarity to C4BP (Miller, 
e.G., et ai, 1997). Miller, e.G., et al (1997) have produced a knockout cowpox 
virus, in which the gene encoding IMP is disrupted. 
This recombinant virus was produced in the following way: The plasmid pGKI0 
containing the open reading frame for vaccinia virus complement control protein 
(YCP) was cleaved with EcoRY. This resulted in the deletion of 70 bp within the 
YCP gene (YCP is the IMP homolog in vaccinia virus). The plasmid pTK61 
(Falkner, F.G. and Moss, B., 1988) containing a gpt cassette was cleaved with 
EcoRI, resulting in the excision of this gpt cassette within a 2 kb fragment. The 
E. coli gene gpt encodes the enzyme xanthine-guanine phosphoribosyltransferase 
(XGPRT), which catalyzes the synthesis of guanine monophosphate (GMP) from 
xanthine monophosphate (XMP), using xanthine (Mulligan, R.e. and Berg, P., 
1981). The 2 kb fragment containing the gpt cassette was then inserted into the 
YCP open reading frame of plasmid pGKIO. This new plasmid was called 
pGK 12. CY -1 mono layers that were infected with CPY were transfected with 
this plasmid, following which the kn ckout virus was plaque purified in medium 
containing mycophenolic acid (MPA), hypoxanthine and xanthine. MPA inhibits 
the synthesis of XMP from inosine monophosphate (IMP) Via IMP 
dehydrogenase. (Miller, e.G., et ai, 1997; Falkner, F.G. and Moss, B., 1988; 
Mulligan, R.e. and Berg, P., 1980). Thus, production of XGPRT by cells 
infected with the recombinant virus will overcome the inhibition of MPA in the 
presence of xanthine, and so plaques formed would be due to the presence of 
recombinant virus, which could then be purified. 
This recombinant virus thus has the YCPIIMP gene disrupted by a 2 kbp 
fragment. This recombinant virus was named vSIGK5 (Miller, e.G., et ai, 1997). 











Cpy IMP- was used in all experiments and compared to wild type Cpy (CPY 
WT) in order to investigate the effect oflMP on plaque and pock morphology and 
viral growth. 
Pock morphology on the chorioallantoic membranes (CAMs) of embryonated 
hens' eggs was once routinely used to identify poxviruses (Baxby, D., 1969). For 
example, the pocks formed by YY are white in colour, whereas those produced by 
CPY are red. The genes responsible for pock colour have been identified in CPY 
(Pickup, D.J., et af, 1986) and rabbitpox virus (RPY) (Martinez-Pomares, L., et 
af, 1993). The pocks produced by CPY are distinguishable from those produced 
by RPY as they are slightly more haemorrhagic. However, Baxby, D. (1969) 
showed the existence of white pock mutants of CPY. In addition to this he 
showed that this mutant strain of CPY could spontaneously revert to producing 
red pocks. These spontaneous revertants were macroscopically indistinguishable 
from wild type CPY. However, they were genetically identical to the white pock 
mutants. Thus pock morphology proved to be an unreliable method for 
distinguishing between various poxviruses. 
Nevertheless, since poxviruses are able to propagate on CAMs, producing pocks 
of varying morphology, it was decided to look at the pock morphology of CPY 
WT and CPY IMP-. CPY IMP- has a disrupted IMP gene. IMP is postulated to 
inhibit the complement system, and thus its presence results in a decrease in 
production of the cleavage products C3a, C4b and C5b, which are involved in the 
attraction of immune cells to the site of infection (Parham, P., 2005). 
Fredrickson, et af (1992) showed that following inocu lation of CPY WT onto the 
CAM, there is only a very small influx of inflammatory cells. In addition, 
Kotwal, et af (1998) found that infection of BALB/c mice in the dorsal connective 
tissue with CPY IMP- resulted in greater mononuclear cell influx at the site of 
infection than in mice infected with CPY WT. Thus it would be interesting to see 






























3.2. Materials and methods 
3.2.1. Growth of virus on the chorioallantoic membranes of 9-11 day old 
embryonated hens' eggs 
CPV WT and CPV IMP', a deletion mutant lacking the inflammation modulatory 
protein (Miller, eG., et ai, 1997), provided by Prof Girish Kotwal, were cultured 
using 9-1 I-day old embryonated hens' eggs, using a modification of the method 
outlined by Joklik, W.K- (\ 962). Eggs were viewed using an egg candler to 
ensure the embryos were the correct age and ascertain the positions of blood 
vessels. Using an egg-pricker, holes were made at the air-sac end and on the 
lateral side of each egg, next to, but not directly above, a large blood vesseL A 
drop of phosphate buffered saline containing penicillin and streptomycin (Gibco, 
Grand Island, New York, USA) at 100 Ulml and 100 Ilg/ml, respectively, was 
placed on the lateral hole. A pipette filler bulb was placed over the hole at the air-
sac end and gentle pressure was applied using the bulb, thus causing the 
chorioallantoic membrane (CAM) to collapse at that region. The eggs were 
placed at 37°C for 1.5 h to allow the membranes to stabilize. 
After removal from 37°C, 100 J-li of virus at various dilutions was injected into the 
lateral hole on each egg using a I ml syringe. The hole was covered with wax to 
prevent contamination. Each egg was swirled gently, and then placed at 37°C for 
72 h. 
After 72 h, the eggs were removed from the incubator. Each egg was cut open 
and the section of CAM that had dropped from the egg shell was collected. The 
membranes were washed by swirling in physiological saline twice. The 
membranes were placed in autoclaved McCartney bottles containing glass beads. 
For each membrane in the tube, 700 l.tI McIlvain's buffer (0.1 M citric acid, 0.2 M 
disodium hydrogen orthophosphate, pH 7.4) (Stannard et ai, 1998) and 170 J-li of 
the organic solvent Arklone-X was added. The tubes containing the membrane-
solvent mixture were shaken vigorously for 2 minutes. The tubes were 











supernatants were collected and transferred to clean McCartney bottles without 
glass beads. McIlvain's buffer and Arklone-X were once again added to the 
membranes in the universal tubes with glass beads, in the same ratio, and the 
mixture was centrifuged at 1 000 rpm for 10 min. This supernatant was then 
added to the supernatant collected previously in the clean universal tubes without 
glass beads. The supernatants from each virus suspension were placed on ice for 
1.5 h. 
The supernatants were then centrifuged for 10 min at 2 000 rpm to remove 
cellular debris. The supernatant fluid was then transferred to sterile centrifuge 
tubes. To each tube 5 ml of 36% sucrose in TE buffer pH 9 (w/v) was added. 
The suspension was then centrifuged at 11 000 rpm for 1 hour at 4°C, in a 
Beckman J2-21 centrifuge, using a JA-20 rotor. The supernatant was then 
discarded and the pellet was resuspended in 0.5 ml TE buffer (pH 9) at 4°C 
overnight. 
3.2.2. Comparison of pock morphology of CPV WT and CPV IMp· on the 
chorioallantoic membrane 
The viruses CPY WT and CPY IMp· were cultured in embryonated hens' eggs 
using a method modified from that outlined by Joklik, W.K. (1962). The protocol 
was followed as indicated in section 3.2.1 until the membranes were harvested 
and rinsed in physiological saline. Thereafter, each membrane was gently spread 
out on a Petri dish using a pair of forceps and then photographed (Nikon Coolpix 
4500). For each egg, 1 x 102 pfu of each virus was used to infect the CAM. 
3.2.3. Cell culture 
3.2.3.1. Maintenance ofCV-l cells 
A CY-I cell line, derived from the African green monkey kidney (Jensen, F.e., et 
ai, 1964) was maintained in cell culture flasks (Greiner Bio-One, Gloucestershire, 
UK) containing Dulbecco's modified Eagle's medium (DMEM) (Gibco, Grand 











(Gibco, Grand Island, New York, USA). The antibiotics penicillin (Gibco, Grand 
Island, New York, USA) and streptomycin (Gibco, Grand Island, New York, 
USA) and an anti-fungal agent, fungin (InvivoGen, Wiltshire, UK), were added to 
the medium to final concentrations of 100 U/ml, 100 J...lg/ml, and 10 !-tg/ml, 
respectively. The cells were incubated at 37°C and 5% CO2. 
Sub-culturing of cells was performed in a biosafety level 2 cabinet. The working 
surface of the cabinet was wiped with 70% ethanol before and after work was 
done. Cell monolayers were sub-cultured once they had reached 90-100% 
confluency. This was done as follows: the DMEM was removed from the flask; 
the monolayer was washed with phosphate buffered saline (PBS); trypsin (Gibco, 
Grand Island, New York, USA) (0.5%) was added to the flask, which was then 
incubated at 37°C and 5% CO2 for 5-10 min to allow for detachment of the 
monolayer from the flask. Once the cells had detached from the flask surface a 
percentage of the cells was transferred to a clean flask and to these cells fresh 
DMEM, supplemented with the appropriate amount of FCS, was added. 
3.2.3.2. Titration of virus stocks 
All virus stocks were titrated on CY -1 cell mono layers in 24-well plates (Cellstar, 
Greiner Bio-One, Frickenhausen, Germany). The titration was performed in 
triplicate. Ten-fold serial d ilutions of each virus were prepared in DMEM. 
Dilutions of 10.3 to 10.9 were used for the titration. The final volume of each 
dilution was I m!. Thus, the appropriate amount of virus stock and DMEM were 
added to each other. Once the monolayers in each well were confluent, the 
medium was removed. Into 3 adjacent wells, 200 !-tl of a particular dilution was 
added. DMEM was used as a negative control. There were 7 groups of weJls to 
which viral dilutions (10-3 to 10-9) had been added as an inoculum, and 1 group to 
which just DMEM had been added as an inoculum. The plate was then placed at 
37°C and 5% C02, and adsorption was allowed for 1.5 h. After 1.5 h the plate 
was removed from the incubator and the inoculum was removed from each well. 
To each well, 500 !-tl DMEM supplemented with 4% FCS was added. The plate 











After 72 h the plate was removed from the incubator and the medium was 
removed from each well. A few drops of carbol-fuchsin (obtained from Medical 
Virology Diagnostic Laboratory, C22, Groote Schuur Hospital) were added to 
each well. After 20-30 s the stain was washed off with water, and the plate was 
allowed to dry in an inverted position on paper towel. The plaques in each well 
were then counted. The total number of plaques for each well was mUltiplied by 5 
(since only 200).11 of inoculum had been added to each well and the final titre is 
expressed as plaque forming units per ml) and the dilution factor was taken into 
account to determine the fina l virus titre of each well. The titres for 3 wells 
inoculated with the same viral dilution were added and divided by three to give a 
final average titre of the virus stock. 
3.2.3.3. Comparison of plague morphology of CPY WT and CPY IMP- on 
CY -1 monolayers 
Viruses were grown in CV -I monolayers. The protocol followed was as outlined 
in section 3.2.3.2.; however, 6-well plates were used. Briefly, serial dilutions of 
each virus were prepared. Of each dilution, 500 III was used to inoculate each 
well. Virus adsorption was allowed for 1.5 h at 37°C, following which the 
inoculums were removed and replaced with DMEM (4% FCS). After 72 h 
incubation at 37°C, the medium was removed form each well and cells were 
stained with carbol fuchsin. 
3.2.4. PCR analysis of CPY WT and CPY IMP- to confirm the presence or 
absence, respectively, of tbe gene encoding IMP 
3.2.4.1 Virus culture in CY-1 monolayers for DNA isolation 
This protocol was adapted from Kellogg, D.E. and Kwok, S. (1990). A 6-well 
plate (Costar, Corning Incorporated, Port Elizabeth, South Africa) was seeded 
with CV -I mono layers in DMEM supplemented with 10% fCS, and placed at 
37°C and 5% C02 until the cells in each well were confluent. CPV WT and CPV 











removed and each well was inoculated with 500 ~I of DMEM containing 105 to 
102 pfu/ml of either CPY WT or CPY IMP-. Adsorption was allowed for 1.5 hat 
37°C. Following adsorption the inoculum was removed from each well and 
replaced with DMEM supplemented with 4% FCS. The plates were then 
incubated at 37°C until cytopathic effect was evident (24-48 h). Once cytopathic 
effect was evident, the cells were scraped off the bottom of the well and 
transferred to an Eppendorftube. The ceIl/medium mixture was centrifuged at 14 
000 rpm (Beckman Microfuge E) for 10 min and the supernatant discarded. To 
the pellet, 25 ~I lysis buffer A (100 mM KCI; 10 mM Tris-HCI, pH 8.3; 2.5 mM 
MgCI2), 25 ~I lysis buffer B (10 mM Tris-HCI, pH 8.3; 2.5 mM MgCb; 1.5% 
Tween-20), and 3~1 of a 10 mg/ml proteinase K solution (Roche, Penzburg, 
Germany) was added. Each sample was incubated at 60°C for I h, and thereafter 
at 95°C for 10 min. Following lysis of the cells, DNA extraction was then 
performed. 
3.2.4.2. DNA Isolation 
To each sample, an equal volume of phenol was added in order to remove all 
proteins. The mixture was then centrifuged for 10 min (Beckman Microfuge E) at 
14 000 rpm. The top layer was transferred to a clean Eppendorf tube and to 
remove all traces of phenol, all equal volume of chloroform:isoamyl (24: 1) was 
added. This was followed by centrifugation at 14 000 rpm for 10 min. The top 
layer was retained once again and to precipitate the DNA, 0.1 volumes of ice cold 
3M sodium acetate and 2.5 volumes of ice cold absolute ethanol was added to it. 
The samples were then placed at -20°C overnight. After removal from 
-20°C, the samples were centrifuged at 14000 rpm for 20 min. The pellets were 
then washed by adding 70% ethanol and centrifuging for 5 min at 14 000 rpm. 












3.2.4.3. PCR to confirm the presence or deletion of the gene encoding 
IMP in CPV WT or CPV IMP-, respectively 
To confirm the presence or absence of the gene encoding IMP in CPY WT and 
CPY IMP-, respectively, primers were designed so that the forward primer would 
bind upstream of the transcription start site, and the reverse primer would bind 
downstream of the stop codon. The forward primer IMP PCR FWD (5' ATC 
TAT TGT GTC GGT AGA CGA 3 ') bound 201 bp upstream of the start codon, 
and the reverse primer IMP PCR REY (5' GCT GTA GAG TAC GAC GGT G 
3 ') bound 404 bp downstream of the stop codon (see figure 3.1). Using these 
primers, products of 1.4 kbp and 3.4 kbp were expected using CPY WT and CPY 
IMP- DNA as a template, respectively. IMP PCR FWD and IMP PCR REY each 
have a T m of 60°C, calculated using the formula T m = 4(G+C) + 2(A+ T), and an 
annealing temperature of 55°C was chosen (5°C below the Tm). 
The workbench was wiped with 70% ethanol before setting up the PCR reactions. 
Plugged tips were used to add all reagents to the reaction tubes. In addition, the 
extracted DNA was added to the specific reaction tube at a separated location. 
For each reaction, 50 pmollJ-l1 of each primer, 2.5U of TaqDNA polymerase, Ix 
PCR buffer, 1.5 mM MgCI2 and 0.2 mM dNTP mixture (Promega, Wisconsin, 
USA) were used. The PCR conditions were as follows: 94°C for 2 min; 30 
cycles of 94°C for I min, 55°C for I min and noc for 2 min; and noc for 10 
min. In addition, as a positive control the primers YCP PCR FWD (5' GAA TIC 
TGC TGT ACT ATI CCG TCA C 3') and YCP PCR REY (5' GCG GCC GCT 
TAG CGT ACA CAT TTI GGA AG 3') (both primers were designed by Dr. 
Tayo Odunuga) were used. The YCP PCR primers bind within the IMP gene, and 
thus an absence of that gene would result in the absence of a PCR product (See 
figure 3.4). CPY WT DNA was used as a positive control. As a negative control, 











3.2.4.4. Agarose gel electrophoresis 
All peR products were subjected to agarose gel electrophoresis on a horizontal 
submerged agarose gel system, using the protocol outlined in Ausubel, et af 
(1988). The agarose was made up in Ix TAE buffer (40 mM Tris base; glacial 
acetic acid 0.014% v/v; 1 mM EDTA, pH8) to give a 1 % gel. This concentration 
ensured that the pore size in the meshwork formed upon polymerization of the 
agarose was adequate to allow efficient passage of the DNA of interest through 
the gel. Ethidium bromide was also added to the gel to a final concentration of 
0.5 Ilg/ml, to allow for visualization of the DNA. 
The peR products were prepared for loading in an area separated from that in 
which the peR reactions were set up. To 15 III of peR product, 1 x loading dye 
(bromophenol blue [0.25% w/v]; sucrose [40% w/v]; EDTA [20mM, pH 8]) was 
added. 
peR product was subjected to agarose gel electrophoresis at 90 V for 1.25 h. The 











34801 atcatctgtt agagtagtat cattaaatct attatatttt 
34841 atgaaagat;a tatcactgct cacctctata tttcgtacat 
34881 ttttaaactg ttt atctctctga tacaatcaga 
3492l ta _ ataccgt tacatttgaa 
34961 ttaatggtgt tccattttac aacttttaac aagttgacca 
35001 attcatttct aatagtatca aactctccat gattaaatat 
35041 tttaatagta tccattttta tatcactacg gatacaaagt 
35081 agctgacata aaaaccattg tataattttt atgttttatg 
3512l tttatta gcg tacacatttt ggaagttccg gctgccatgt 
35161 atttcctgga gagcaagtag atgatgagga accagatagt 
35201 ttatatccgt gtctgcactt aaagtctaca ttgtcgttgt 
35241 gtgagtatga tcttttaaac ccgctagaca agtatccgtt 
35281 tgttattgaa ggatgtgggc atttaacgat ctgacacgtg 
35321 ggtggatcgg accattctcc tcctgaacac acgatgccag 
35361 agttaccaat caacgaatat ccactattgc aactatacgt 
35401 tacaacgctt ccatcggtat aaaaatcctc gtatccgtta 
35441 tgccttccat tggttacaga tggaggggat gggcatttaa 
35481 cagattcaca aatgggtgcc tcgggattcc acaccataga 
35521 tccagtatat cctagttcac aatacgattt agattctcct 
35561 atcaactgat atccgctatt gcaagagtac gttatactag 
35601 agccaaactc tactccacca atatcaattt gaccattatc 
35641 aatatctcga ggtgatggac atttccgttt aatacattga 
35681 ttaaagagtg tccatccagt acctgtacat ttagcatata 
3572l taggtcccat tttttgcttt ctgtatccag gtagacatag 
35761 atattctata gtgtctccta tgttgtaatt agcattagca 
35801 tcagtcccca cactattctt aaatttcata ttaatgggac 
35841 gtgacggaat agtacagcat gatagcacgc atcctattcc 
35881 caacaatgtc aggaacgtca cgctctccac cttcatattt 
3592l atttatccgt aaaaatgtta tcctatgcat tgtccaataa 
35961 taaaaagtca tgctattgta ggaattgttt ttcacagttg 
36001 ctcaaaaacg atggtagtga cttacgagtt acgttacact 
36041 ttggagtctc atctttagta aacatatcat aatattcgat 
36081 attacgagtt gacatatcga acaaattcca agtatttgat 
36121 tttggataat attcgtattt tgcatctgct ataattaaga 
36161 tataatcacc gcaagaacac acgaacatct ttcctacatg 
36201 gttaaagtac atgtacaatt ctatccattt gtcttcctta 
36241 actatatatt tgtatagata 
36281 ttccagtaat tacatagatg 
3632l ataaactata ctatgatgtc taggcatggg agactttttt 
36361 atccaacgat ttttagtgaa acattccaca tcgtttaata 
36401 ctacatattt ctcatacgtg gtataaactc cacccattac 
36441 atatatatca tcgtttacga ataccgatgc gcctgaatat 
36481 ctaggagtaa ttaagtttgg aagtcttatc catttcgaag 
36521 tgtcgtgttt caaatattct gctacacccg ttgaaataga 
36561 aaattctaat cctcctatta catataactt tccatcgtta 
Figure 3.1: Figure showing a segment of the CPV genome. The start and stop 
codons of the IMP gene are highlighted in yellow. The IMP PCR FWD and 



















404 bp IIVIP peR 
REV 
binding site 
Fig 3.2: Schematic diagram of the IMP PCR FWD and IMP PCR REV primer 
binding sites, showing the location of the IMP gene within the CPV WT 
















Fig 3.3: Schematic diagram of the IMP PCR FWD and IMP PCR REV primer 
binding sites, showing the location of the inserted gpt cassette within the VCP 











1 tttttattat ttgtacgatg tccaggataa catttttacg 
41 tatgaaggtg gagagcg 
Sl ataggatgcg ttctatc 
121 ac ccattaatat gaaatttaag aatagtgtgg 
161 agactgatgc taatgctaat tacaacatag gagacactat 
201 agaatatcta tgtctacctg gatacagaaa gcaaaaaatg 
241 ggacctatat atgctaaatg tacaggtact ggatggacac 
2S1 tctttaatca atgtattaaa cggagatgcc 
321 at aatggccaac ttgatattgg 
361 tttggctcta gtataacgta ctcttgtaat ag 
401 atttgatcgg tgaatctaaa tcgtattgtg aattaggatc 
441 tactggatct atggtatgga atcccgaggc acctatttgt 
4S1 gaatctgtta aatgccaatc ccctccatct atatccaacg 
521 gaagacataa cggatacgag gatttttata ccgatgggag 
561 cgttgtaact tatagttgca atagtggata ttcgttgatt 
601 ggtaactctg gtgtcctgtg ttcaggagga gaatggtccg 
641 atccacccac gtgtcagatt gttaaatgtc cacatcctac 
6S1 aatatcaaac ggatacttgt ctagcgggtt taaaagatca 
721 tactcataca acgacaatgt agactttaag tgcaagtacg 
761 gatataaact atctggttcc ctt 
SOl aggaaataca tggaagccgg 
Figure 3.4: Figure showing VCP gene sequence. The start codon of the VCP 
gene is highlighted in yellow. The VCP PCR FWD and VCP PCR REV 
primer binding sites are highlighted in magenta. The EcoRV cleavage sites are 












3.3.1. Growth of virus on tbe chorioallantoic membranes of 9-11 day old 
embryonated hens' eggs 
Cpy WT and CPY IMP- were cultured on embryonated hens' eggs CAMs. The 
method used was a modification of that described by Joklik, W.K. (1962). Each 
egg was candled to ensure that it was fertilized and that the embryo was at the 
correct age. The embryos were found to be between 9 and 11 days old. Twelve 
eggs were used for each virus. Eleven were infected with either CPY WT or CPY 
IMP-, and the twelfth egg was mock-infected with PBS. The 2 viruses were 
cultured at different times to prevent cross-contamination of stock cultures. 
After 72 h incubation at 37°C, the membranes were harvested. On the 
membranes infected with virus, red pocks were visible and dilation of blood 
vessels was evident. In contrast, the mock-infected membranes did not have any 
pocks and there was no visible dilation of the blood vessels. 
The virus extracted from the CAMs was stored at -80° or -20°e. The titre of each 
virus stock was determined by titration on CY-l monolayers (section 3.3.3.) . The 
average titre per egg for CPY WT was 1.88 x 108 pfu/egg, and for CPY IMP- was 
5.05 x 108 pfu/egg. 
3.3.2. Comparison of pock morphology of CPV WT and CPV IMP- on the 
chorioallantoic membrane 
CPY WT and CPY IMP- were propagated on chick egg membranes in order to 
compare the pock morphology of each virus. Figure 3.5 shows the images 
captured. 
There was no difference in the appearance of the pocks produced by the 2 viruses. 











wnFig 3.5: Figure showing CAMs of 12-14-day old chick embryos, infected with Cpy WT (right) and CPY IMP- (left). Membranes were infected with] x 102 
pfu of each virus, and the eggs were incubated at 37°C for 72 h before harvesting 
of the membranes. A few pocks in each picture are circled. Arrows indicate blood 
vessels. 
3.3.3. Titration of virus stocks 
The titre was obtained as follows: The group of 3 wells infected with the dilution 
which yielded 10-100 plaques per well, was chosen for counting. The plaques in 
each of these three wells were counted, and each number was then multiplied by 
5, to determine the number of plaques per m I, and then multiplied by the dilution 
factor. The 3 titres obtained for each well were averaged. Table 3 shows the 
average titres obtained for each titration. For CPY WT, a titre of 2.07 x 109 












Table 3: Table showing the number of plaques counted and the calculated titre 
for each virus. 
Virus #plaques x5~ X dilution Average 
counted factor titre 
(dilution usedt (pfu/ml) 
CPV IMP' 117 (I x 10") 585 275 x 10' 5.55 x 10'1 
116 (1 x 10") 580 255x10' 
lOa (I x 10") 500 240 X 10' 
CPYWT 52 (I x 10") 260 260 x la' 2.07 x 10'1 
32 (I x 10") 160 160 x 10' 
40 (I x 10") 200 200 X la' 
~The number of plaques was multiplied by 5 as 200 fll was used as inoculum in 
each well, and the titre is expressed as pfu/ml. 
Fig. 3.6: This is an example of a titration plate. 24-well plates were seeded with 
CY -I mono I ayers, which were then infected with CPY WT, using serial dilutions 
of the virus. 72 h following infection, the infected monolayers were stained with 
carbol-fuchsin. Purple regions indicate the presence of cells, whereas the clear 
regions indicate the formation of plaques on the mono layers. Numbers indicate 
the dilution of virus used to inoculate a well and the 2 adjacent wells to the right. 
C indicates 3 adjacent wells inoculated with DMEM as a negative control. 
3.3.4. Comparison of plague morphology of CPV WT and CPV IMP' on 
CV-l monolayers 
CPY WT and CPY IMP' were used to infect CY- I mono layers. After 72 h of 
incubation at 37°C after infection of the monolayers, the cells were stained with 











or CPV IMP-. Purple regions are viable cells that have taken up the stain. Clear 
dots are plaques formed when virus enters the cells and induces cytopathic effect. 
Fig. 3.7: Figure showing CV-1 mono layers infected with CPV WT (left) and CPV 
IMP- (right), and stained with carbol-fuchsin. A few plaques on each plate are 
circled. 
3.3.5. PCR analysis of CPV WT and CPV IMP- to confirm the presence or 
absence, respectively, of the gene encoding IMP 
Figure 3.8 shows the PCR products which were subjected to agarose gel 
electrophoresis. The molecular weight marker Roche marker VII (Roche, 
Penzburg, Germany) was used. In lane 2 is the negative control (i.e. no DNA). In 
lane 3, a ~ 1400 bp product was obtained from CPV WT, as expected using the 
cowpox virus IMP primers (see section 3.2.3.3). Similarly, the expected product 
of 3400 bp was obtained from CPV IMP-, using the cowpox virus IMP primers 
(lane 4). 
In lane 5, a PCR product of ~ 740 bp was obtained from CPV WT, using the 
vaccinia virus VCP primers, whereas no PCR product is present in lane 6, from 
CPV IMP-. This is as expected as the vaccinia virus VCP primers bind within the 
















1 2 3 4 5 6 
Figure 3.8: Figure showing PCR products following electrophoreses on a 1% 
agarose gel. Lane I: molecular weight marker; lane 2: negative control; lane 
3: 1396 bp product amplified from CPY WI using IMP PCR primers; lane 4: 
3400 bp product amplified from CPY IMP- using IMP PCR primers; lane 5: 
734 bp product amplified from CPY WI using YCP PCR primers; lane 6: no 












The chorioallantoic membrane of the chick embryo was chosen as a system for 
large scale growth of CPV WT and CPV IMP-, as it has been shown that high 
yields of orthopoxviruses can be recovered from it (Joklik, W.K., 1962)_ For 
cowpox virus in particular, high yields of viral plaque forming units (pfu) are 
obtained, with Joklik reporting a titre of 1 x 109 pfu per membrane. Here I have 
shown that the recombinant virus, CPV IMP-, is able to grow to as high a titre as 
the wild type virus, CPV WT. I obtained a titre of 1.88 x 108 pfu per egg for CPV 
WT and 5.05 x 108 pfu per egg for CPV IMP-. 
The CAM was not chosen for determination of viral titres, however. Rather the 
cell culture system was used_ Virus was titrated on CV-I mo olayers. For 
greater accuracy of the titration, wells were infected in triplicate and an average 
was obtained from the three wells. For CPV WT, an average titre of 2.07 x 109 
pfu/ml was obtained from II eggs and an average titre of 5.55 x 109 pfu/ml was 
obtained for CPV IMP- from II eggs. 
PCR analysis of the wild type and knockout virus confirmed the presence and 
absence, respectively, of the gene encoding IMP. PCR products of the 
appropriate size were obtained for both viruses. For CPV WT, a product of 1396 
bp in size was obtained, using the primers IMP PCR FWD and IMP PCR REV. 
This accounted for the size of the IMP open reading frame (792 bp), the number 
of bases upstream of the IMP ORF, where IMP PCR FWD binds (201 bp), and 
the number of bases downstream of the IMP ORF, where IMP PCR REV binds 
(404 bp). A product of3326 bp in size was amplified from CPV IMP- using these 
primers. This total was made up of the gpt cassette inserted into the VCP ORF 
(2000 bp), the VCP ORF missing 70 bp (722 bp), plus the 201 bp upstream and 
404 bp downstream of the VCP ORF. This confirms that CPV WT has the IMP 
gene present in its genome, and that CPV IMP- has an IMP gene that is disrupted 
by a deletion of 70 bp and an insertion of 2 kbp_ A band of 1396 bp was not 
amplified from CPV IMP- template DNA, showing that the virus preparation is 











No difference was seen between the plaque morphology ofCPV WT and 
CPV IMP- in CV -1 cells_ As shown in fig_ 3_7, the plaques produced were similar 
and indistinguishable with respect to size and shape. This was not a surprising 
result as there is no immune system present in cell culture and IMP is presumed to 
function as a complement binding protein. 
The pocks produced on the chorioallantoic membrane of embryonated hens' eggs 
by wild-type cowpox virus (in this project, the virus termed CPV WT), have been 
well characterized. Palumbo et al (1989) and Fredrickson et al (1992) both 
described pocks that were red in colour due to the dilation of blood vessels and 
excessive accumulation of blood at the regions of viral replication (i.e. the pocks). 
The red pock characteristic of CPV WT is due to CrmA, which belongs to the 
serpin superfamily of proteins (Pickup, DJ., et aI, 1986). CrmA i hibits caspase 
1 (Ray, C.A., et aI, 1992), a serine protease that converts pro-IL-113 to the mature 
IL-113 (Thornberry, N.A., et aI, 1992). IL-113 is a pro-inflammatory cytokine 
(Dinarello, C.A., 1989). Viruses with a ermA deletion have been shown to 
produce white pocks on the chick CAM, with an influx of inflammatory cells into 
the pock responsible for this white colour (Palumbo, GJ., et aI, 1989). 
In this experiment, CPV WT and CPV IMP- both produced pocks which were 
bright red in colour and similar in size. Although the morphology appears to be 
the same, it is not known whether the lack of IMP attenuates viral growth or not. 
Thus in the next chapter a series of growth curves is described, which aim to 












COMPARISON OF GROWTH CHARACTERISTICS OF 
CPV WT AND CPV IMP- IN CV-l MONOLAYERS AND 
EMBRYONATED HENS' EGGS 
4.1. Introduction 
4.2. Materials and methods 
4.2.1. Quantitation of CV -I cells on a 25 cm3 surface area 
4.2.2. Viral growth curves generated by growth ofCVP WI and CPV 




2.9 x 10-5 or 2.9 x 10-3 pfu/cell 55 
4.2.3. Viral growth curves generated by growth ofCPV WI and CPV 
IMP- on chick chorioallantoic membranes using either I x 102 or 
I x 104 pfu per egg membrane 57 
4.3. Results 59 
59 4.3.1. Quantitation of CV -1 cells on a 25 cm3 surface area 
4.3.2. Viral growth curves generated by growth ofCPV WI and CPV 
IMP- in CV -1 monolayers 59 
4.3 .2.1. Viral growth curve generated using a multiplicity of infection 
of 2.9 x 10-5 pfulcell in CV -I mono layers (1 x 102 pfu/flask) 59 
4.3.2.2. Viral growth curve generated using a multiplicity of infection 
of2.9 x 10-3 pfulcell in CV-I monolayers (1 x I04pfu/flask) 61 
4.3.3. Viral growth curves generated by growth of CPV WI and CPV 
IMP- on chick chorioallantoic membranes 65 
4.3.3. J. Viral growth curve generated using I x 102 pfu/egg membrane 65 
4.3.3.2. Viral growth curve generated using 1 x 104 pfuJegg membrane 66 












The experiments performed in this chapter were set up to determine whether IMP 
influences growth of the virus in CY-I cells and on chick CAMs. To do this, 
growth curves were generated, which are plots of virus titre against time. Growth 
curves are useful for examining viral growth under many conditions. For 
example, they have been used to study the growth of modified vaccinia virus 
Ankara in different cel.1 lines (Drexler, 1., et ai, 1998); to evaluate the dependence 
or resistance of vaccinia virus mutants in the presence or absence of a particular 
compound (Katz, E., et ai, 1973); to determine the effect of partial gene knockout 
and replacement with homologous repeats on growth of vaccinia virus (Meng, X. 
and Xiang, Y., 2006); and to determine the effect of gene knockout and protein 
complementation on the growth of vaccinia virus (Ramsey-Ewing, A.L. and 
Moss, B., 1996). 
Firstly, viral growth in vitro was investigated. For this, CY -1 monolayers were 
infected with CPY WT or CPY IMP-. Previous work has shown that vaccinia 
virus YCP is not necessary for growth in cell culture (Kotwal, GJ., et ai, 1990). 
Since IMP is a homolog of YCP, the hypothesis is that this CPY protein should 
not be required for growth in cell culture. This has been shown to be true by the 
construction of the deletion mutant CPY IMP-, which form plaques in cell culture. 
However, IMP is has not yet been characterized with respect to its binding 
properties and also its role in replication of CPY in vitro. Thus until the 
experiment is performed one cannot make any deductions as to its role in viral 
growth in vitro. 
Secondly, growth curves were generated in ovo, i.e. in embryonated hens' eggs. 
The CAM of the chicken egg has been shown to support the growth of all 
orthopoxviruses (Joklik, W.K., 1962). In addition, experiments have been 
performed using mutant forms of the wild type orthopoxviruses (Palumbo, GJ., et 
ai, 1989), and the characteristics of these mutants with respect to pock 
morphology and immune properties were determined, relative to the wild type 






















4.2. Materials and Methods 
4.2.1. Quantitation of CV-1 cells on a 25 cm3 surface area 
Cells were counted to determine the number of cells in a 25 cm2 flask once the 
monolayer had reached 100% confluency. The cells were detached from the flask 
surface by addition of trypsin and incubation at 37°C for 5-10 min. The 
cell/trypsin mixture was transferred to a sterile tube, and 5 ml DMEM was added 
to it. To a clean eppendorf tube, 50 ~I trypan blue (Sigma-Aldrich, UK) was 
added. To this 50 ~I trypan blue, 50 ~I of the cellltrypsinIDMEM mixture was 
added. A drop of this mixture was placed on a cell counting chamber 
(Marienfeld). A coverslip was placed over the drops and the slide was viewed 
using an Olympus CK30 microscope at 4x magnification. 
Cells in 2 out of the 9 chambers were counted and the number was averaged. 
However, to account for the 1:2 dilution of the cells in trypan blue, this average 
number was then multiplied by 2. The number of cells was calculated using the 
formula c = n/v, where c is the number of ceII s/mI, n is the number of cells, and v 
is the volume in m!. Since the depth of the chamber is 0.1 mm, and the area of 
each square is I mm2, the volume of each square is 0.1 mm3, or I x 10-4 m!. Thus, 
the number of cells is calculated using the formula c = n x 104 (Freshney, l.R., 
1994). 
4.2.2. Viral growth curves generated by growth of CPV WT and CPV 
IMP- in CV-1 monolayers using multiplicities of infection of either 
2.9 x 10-5 or 2.9 x 10-3 pfu/celJ 
Eighteen small flasks with a surface area of25 cm3 were seeded with CY-I cells. 
The cells were maintained in DMEM supplemented with 10% FCS, until 
confluent. Once confluent (± 3.5 x 106 cellsif1ask), the medium was removed 
from each flask. To 9 flasks, I x 102 pfu of CPY WT, in I ml of PBS, was added. 
To the remaining 9 flasks, I x 102 pfu of CPY IMP-, in I ml of PBS, was added. 











The multiplicity of infection is the ratio of the number of virus particles present to 
the number of CY -1 cells present. In this case for every cell present, there were 
0.0000287 virus particles. The flasks were placed in a 37°C and 5% C02 
incubator, and virus adsorption was allowed for 2 hours. Following adsorption, 
the flasks were removed from the incubator and the inoculum removed. DMEM 
supplemented with 4% FCS was then added to each flask. The flasks were again 
placed in the 37°C incubator. 
At various time-points, one flask with a CPY WT-infected monolayer, and one 
flask with a CPY IMP·-infected monolayer were removed from the incubator and 
placed at -20°C immediately. These time-points were: 0 h (once the inoculum 
was removed and replaced with DMEM, the flask was placed at -20°C 
immediately), 6 h, 12 h, 24 h, 30 h, 36 h, 48 h, 60 hand 72 h. 
To lyse the CY -1 cells and release the intracellular virus, three cycles of freeze-
thawing was carried out at -20°C and 37°C, respectively. The virus-containing 
med ium from each time-point was then titrated on CY -I cells in 24-well plates, as 
outlined in chapter 3. Cells were infected in triplicate. The inoculum was 
allowed to adsorb to the cells for 1.5 h. After removal of the inoculum, 0.5 ml 
DMEM supplemented with 4% FCS was added to each well. The plates were 
incubated at 37°C and 5% CO2 for 72 h. The plates were then removed from the 
incubator, and the medium was removed from each well. To each well, a few 
drops of carbol-fuchsin were added, and staining of the cells was allowed for 20-
30 sec. The stain was then rinsed off with water and the plates were inverted to 
allow for drying. Once dry, the plaques in each well were counted and the viral 
titre at each time-point was calculated. 
The same procedure described above was carried out, this time using 1 x 104 pfu 
of CPY WT in I ml PBS, or 1 x 104 pfu of CPY IMp· in I ml PBS as an 
inoculum. This corresponds to an MOl of 2.87 x 10.3 pfulcell. Thus in this 
experiment, for every cell present there were 0.00287 virus particles. Titration of 
virus extract from each time-point was carried out on the same day to ensure that 











4.2.3. Viral growth curves generated by growth of CPV WT and CPV 
IMP- on chick chorioallantoic membranes using either 1 x 102 or 1 x 
104 pfu per egg membrane 
Forty 9-11-day old embryonated hens' eggs were used in this experiment. Using 
an egg-pricker, holes were made at the air-sac end and on the lateral side of each 
egg, next to but not directly above any blood vessels. A drop of PBS containing 
penicillin and streptomycin was placed on top of the hole. A pipette filler bulb 
was placed over the hole at the air-sac end and gentle pressure was applied using 
the bulb, thus causing the chorioallantoic membrane (CAM) to collapse at that 
region. The eggs were placed at 37°C overnight to allow the membranes to 
stabilize. 
After removal of the eggs from 37°C, 100 III of PBS containing 1 x 102 pfu of 
CPV WT was injected into each of 20 eggs, and 100 III of PBS containing 1 x 102 
pfu of CPV IMP- was injected into each of the remaining 20 eggs, using 1 ml 
syringes. The lateral holes were covered with wax to prevent bacterial 
contam ination. Each egg was swirled gently for 10-20 sec, and then placed at 
37°C. 
At different time points (2, 24, 48 and 72 h), 5 eggs infected with CPY WT and 5 
eggs infected with CPY IMP- were removed from the incubator. Each egg was 
cut open and the section of CAM that had dropped from the eggsheJJ was 
collected. The membranes were placed in autoclaved McCartney bottles tubes 
containing glass beads. For each membrane in the tube, 1 ml McIlvain's buffer 
(0.1 M citric acid, 0.2 M disodium hydrogen orthophosphate, pH 7.4) (Stannard et 
ai, 1998) was added. The tubes containing the membrane-solvent mixture were 
shaken vigorously for 2 min, and then placed on ice for 10 min. The tubes were 
once again shaken vigorously for 2 min. The membrane-solvent mixtures were 
then placed on ice for 1.5 h. 
The tubes were then centrifuged for 10 min at 2 000 rpm in a Sigma 301K 
centrifuge to remove cell debris. The supernatants containing released virus 











from virus extracted from the eggs at 2 h after infection was taken as the zero 
time-point for the growth curve. 
The virus extracted at each time point was immediately placed at -20°e. 
Following this, serial dilutions of each virus extract were made, and the titration 
was performed on CV -1 monolayers in 24-well plates. The titrations were carried 
out as outlined previously. Briefly: titration of each dilution was performed in 
triplicate; 200 III of inoculum was added to each well; adsorption was allowed for 
1.5 h at 37°C and 5% CO2, following which the inoculum was removed and 
replaced with DMEM supplemented with 4% FCS. The plates were placed at 
3rc for 72 h, at which point they were removed from the incubator, the 
inoculum was removed, and the cells stained with carbol-fuchsin. Titration of 
virus extract from each time-point was carried out on the same day to ensure that 
conditions were uniform for each titration. 
The same procedure described above was carried out, this time using] x ] 04 pfu 
of CPV WT to infect each of 20 eggs, and 1 x 104 pfu of CPV IMP- to infect each 












4.3.1. Quantitation ofCV-l cells on a 25 cm2 surface area 
Cells were counted using a Coulter counter. The number of cells in 2 squares was 
58. The number of cells/ml was calculated using the formula c=n x 104 (refer to 
section 4.2.1). This gave a total of 58 x 104 cells/ml. The cells in a flask with a 
surface area of 25 cm2 were suspended in 6 ml of DMEM, before counting. 
Therefore it was calculated that a 25 cm2 flask, contained approximately 3.48 x 
106 cells. 
4.3.2. Viral growth curves generated by growth of CPV WT and CPV 
IMP- in CV-l monolayers using multiplicities of infection of either 
2.9 x 10-5 or 2.9 x 10-3 pfu/cell 
4.3.2.1. Viral growth curve generated using a multiplicity of infection of 
2.9 x 10-5 pfu/cell on CV-l monolayers (1 x 102 pfu/flask) 
Each flask containing 3.48 x 106 cells was infected with 102 pfu of virus. This is 
equivalent to and Mor of 2.87 x 10-5 pfu/cell (100/3.48 x 106 = 2.87 x 10-5). 
Tables 4.1 (page 60) and 4.2 (page 61) show the average titres obtained at various 
time-points ranging from 0 h to 72 h, following inoculation ofCY-1 monolayers 
with 1 x 102 pfu of either CPY WT or CPY IMP-, respectively. Figure 4.1 (page 
68) is a graphical display of the viral titres over time. 
The growth rates of the two viruses are similar. Initially, fewer CPY IMP-
particles are recovered, as seen at the first three time-points, but this is probably 
insignificant as the numbers are small. By 24 hours the titre of CPY IMP- is the 
same as that of CPY. Figure 4.1 shows that the rate of replication of the two 
viruses is similar. By 48 h both viruses attained titres of more than 1 x 104 pfu/ml. 











Table 4.1: Table showing average titres obtained at various time-points following 
infection ofCY-1 monolayers with CPY WT at an MOl of2.87 x 10-5 pfu/cell 
(I x 102 pfu/flask) 
Time post- Number of Number of Titre (pfu/ml) A verage titre 
infection (h) plaques plaques (ufu/ml) 
(dilution multiplied by 
counted) 5 
0 0(0) 0 0 5 
2 (0) 10 10 
I (0) 5 5 
6 2 (0) 10 10 10 
3(0) 15 15 
1(0) 5 5 
12 2 (0) 10 10 10 
3 (0) 15 15 
I (0) 5 5 
24 116 (0) 580 580 5.85 x 10L 
118 (0) 590 590 
117 (0) 585 585 
30 78 (1 x 10- 1) 390 3900 3.42 x loj 
62 (1 x 10- 1) 310 3100 
65 (1 x 10-1) 325 3250 
36 114 (1 x 10- 1) 570 5700 5.27x1Oj 
105 (1 x 10- 1) 525 5250 
97 (I x 10- 1) 485 4850 
48 86 (1 x IO- L ) 430 43000 4.73 x 104 
94 (1 x IO-L ) 470 47000 
1 04 (I x 10-2 ) 520 52000 
60 100 (1 x 10-2) 500 50000 5.68 X 104 
122 (I x 10-2 ) 610 61000 
119 (I x 10-2 ) 595 59500 
72 56 (1 x 10-j) 280 280000 2.92 x 10) 
66 (1 x 10-5 ) 330 330000 
53 (1 x IO-
j
) 265 265000 
A student's t test was performed using Excel. For all except 2 time-points, the p 
values returned by the programme were greater than 0.05 , indicating that for most 












Table 4.2: Table showing average titres obtained at various time-points following 
infection of CY -I monolayers with CPY IMp· at an MOl of2.87 x 10.5 pfu/cell 
(I x 102 pfu/flask). 
Time Number of Number of Titre (pfu/ml) Average titre 
post- plaques pJaques (~fu/ml) 
infection (dilution multiplied by 
(h) counted) 5 
0 0(0) 0 0 1.67 
0(0) 0 0 
I (0) 5 5 
6 1 (0) 5 5 3.33 
0(0) 0 0 
I (0) 5 5 
12 0(0) 0 0 1.67 
1 (0) 5 5 
0(0) 0 0 
24 97 (0) 485 485 4.50 x 10L 
83 (0) 415 415 
90 (0) 450 450 
30 70 (1 x 10- 1) 350 3500 4.02 x 10'; 
77 (1 x 10-1) 385 3850 
94 (1 x 10- 1) 470 4700 
36 24 (I x lO-L) 120 12000 1.53 x 104 
28 (l x IO-L) 140 14000 
40 (I x IO-L) 200 20000 
48 36 (1 x IO-L) 180 18000 2.60 x 104 
56 (I x IO-L) 280 28000 
64 (I x 10-2) 320 32000 
60 136 (I x 10-2) 680 68000 7.42 x 104 
141 (I x 10-2) 705 70500 
168 (I x 10-2 ) 840 84000 
72 69 (1 x IO-J) 345 345000 3.33x10) 
61 (1 x 10-J) 305 305000 
70 (1 x 10-5 ) 350 350000 
4.3.2.2. Viral growth curve generated using a multiplicity of infection of 
2.9 x 10-3 ~fu/cell on CV-l monolayers (1 x 104 pfu/flask) 
In this experiment, a higher viral titre was used to inoculate each flask. This was 
done in order to determine whether using a higher titre influences the rate of 
replication and whether there are enough cells to support the propagation of the 
increased number of virus particles. Tables 4.3 (page 62) and 4.4 (page 64) show 
the average titres obtained at various time-points ranging from 0 h to 72 h, 











Table 4.3: Table showing average titres obtained at various time-points following 
infection of CV -I monolayers with CPV WT at an MOr of 2.87 x 10-3 pfu/cell (I 
x 104pfu/flask). 
Time Number of Number of Titre (pfu/m!) Average titre 
post- plaques plaques (Ufu/mll 
infection (dilution multiplied by 
(h) counted) 5 
0 27 (0) 135 135 1.43 x 10L 
31 (0) 155 155 
28 (0) 140 140 
6 28 (0) 140 140 1.52 x 10L 
29 (0) 145 145 
34 (0) 170 170 
12 49 (I x 10-') 245 2450 1.95 x 10J 
31 (I x IO- J) 155 1550 
37 (1 x 10- 1) 185 1850 
24 40 (1 x 10-J) 200 200000 2.10 x 105 
44 (I x 10-J) 220 220000 
30 101 (I x IO-~) 505 505000 4.83 x I O~ 
92 (I x IO-~) 460 460000 
97 (I x IO-~) 485 485000 
36 107 (1 x IO-~) 535 535000 6.13x 105 
144 (1 x 10-) 720 720000 
I I 7 (I x IO-J) 585 585000 
48 44 (I x 10-4) 220 2200000 2.85 x lOb 
44 (I x 10-") 220 2200000 
83 (1 x 10-") 415 4150000 
60 52 (I x 10-4) 260 2600000 2.65 x 10° 
47 (I x 10-4) 235 2350000 
60 (1 x 10-'1) 300 3000000 
72 55 (I x 10-") 275 2750000 2.13 x lOb 
39 (l x 10-") 195 1950000 
34 (I x 10-") 170 1700000 
or CPV IMP-, respectively. Figure 4.2 (page 68) is a graphical display of the viral 
titres over time. 
By 48 h there is an increase of approximately 104, from ± 102 pfu/ml at 0 h to ± I 06 
pfu/ml at 48 h. This increase is much the same as that seen when I x 102 pfu of 
virus was used to infect the monolayers (fig. 4.1), when an increase from I x 100 
at Oh approximately 104 at 48 h was seen. For all except 3 time-points, the p 































Table 4.4: Table showing average titres obtained at various time-points following 
infection of CV -I mono layers with CPV IMP- at an MOl of 2.87 x 10-3 pfu/ceJ I (I 
x 104 pfu/flask). 
Time Number of Number of Titre (pfu/ml) Average titre 
post- plaques plaques (pfu/ml) 
infection (dilution multiplied by 
(h) counted) 5 
0 36 (0) 180 180 1.50 x 10L 
27 (0) 135 135 
27 (0) 135 135 
6 II (0) 55 55 8.61 x 10 1 
17 (0) 85 85 
24 (0) 120 120 
12 45 (0) 225 225 2.93 x 10L 
66 (0) 330 330 
65 (0) 325 325 
24 103 (l x IO-L ) 515 51500 5.07 x 104 
99 (I x IO-L ) 495 49500 
102 (I x IO-L ) 510 51000 
30 181 (I x IO-L ) 905 90500 9.07 x 104 
177 (I x IO-L ) 885 88500 
186 (I x 10-L ) 930 93000 
36 106 (I x IO-J ) 530 530000 5.05x10) 
100 (1 x IO-J ) 500 500000 
97 (I x IO-J ) 485 485000 
48 153 (I x lO-J ) 765 765000 7.73 x 10) 
155 (I x IO-J ) 775 775000 
156 (I x IO-J ) 780 780000 
60 47 (I x 10-4 ) 235 2350000 1.92 x J00 
44 (I x 10-4 ) 220 2200000 
24 (l x 10-4 ) 120 1200000 
72 31 (I x 10-4) 155 1550000 1.35 x 10° 
26 (l x 10-4) 130 1300000 











4.3.3. Viral growth curves generated by growth of CPV WT and CPV 
IMP- on chick chorioallantoic membranes using either 1 x 102 or 
1 x 104 pfu per egg membrane 
4.3.3.1. Viral growth curve generated using 1 x 102 pfu/ egg membrane 
Tables 4.5 (page 65) and 4.6 (page 66) show the viral titres obtained at 0, 24, 48 
and 72 h, after crude extraction of virus from the CAMs of embryonated hens' 
eggs infected with 1 x 102 pfu of either CPY WT or CPY IMP-. Figure 4.3 (page 
69) is a graphical display of the viral titres over time. 
A rapid increase is seen in virus titre over 48 h. For both viruses there is a 7 log 
increase from 0 h to 48 h. Between 48 and 72 h, the curve tends to plateau. The p 
value obtained for each time-point using I x 102 pfu/membrane were greater than 
0.05 for all except one time-point. Thus, as with growth in CY-l mono layers, the 
growth of the two viruses in ovo is not statistically different at most time-points. 
Table 4.5: Table showing average titres obtained at 0, 24, 48 and 72 h following 
infection of embryonated hens' eggs with 1 x 102 pfu ofCPY WT. 
Time Number of Number of Titre (pfu/ml) A verage titre 
post- plaques plaques (pfu/ml) 
infection (dilution multiplied by 
(h) counted) 5 
0 0(0) 0 0 0 
0(0) 0 0 
0(0) 0 0 
24 63 (I x IO-L ) 315 31500 2.92 x 104 
58 (I x IO-L ) 290 29000 
54 (t x IO-L ) 270 27000 
48 55 (1 x 10-)) 275 27500000 3.03 x 10' 
62 (I x 10-)) 310 31000000 
65 (I x 10-)) 325 32500000 
72 94 (I x 10-)) 470 47000000 5.00 x 10' 
96 (I x 10-)) 480 48000000 











Table 4.6: Table showing average titres obtained at 0, 24, 48 and 72 h following 
infection of embryonated hens' eggs with I x 102 pfu ofCPY IMP-. 
Time Number of Number of Titre (pfu/ml) A verage titre 
post- plaques plaques (~fu/mll 
infection (dilution multiplied by 
(h) counted) 5 
0 0(0) 0 0 0 
0(0) 0 0 
0(0) 0 0 
24 72 (I x IO-L ) 360 36000 3.33x 104 
63 (I x IO'L) 315 31500 
65 (I x IO-L) 325 32500 
48 48 (I x 10') 240 24000000 2.82 x 10' 
67 (1 x 10-) 335 33500000 
54 (I x 10-) 270 27000000 
72 50 (I x 10') 250 25000000 2.42 x 10' 
50 (I x 10') 250 25000000 
45 (I x 10-) 225 22500000 
4.3.3.2. Viral growth curve generated using 1 x 104 pfu/egg membrane 
Tables 4.7 (page 67) and 4.8 (page 67) show the viral titres obtained at 0, 24, 48 
and 72 h, after crude extraction of virus from the CAMs of embryonated hens' 
eggs infected with I x 104 pfu of either CPY WT or CPY IMP'. Figure 4.4 (page 
69) is a graphical display of the viral titres over time. 
As when the CAMs were infected with I x 102 pfu of virus, there is a rapid 
increase in viral titre over the first 48 h, after which the curve plateaus. However, 
this plateau is not as marked as that seen when eggs were infected with I x 102 pfu 
of virus. The p values obtained for I x 104 pfu/membrane at all time-points were 
less than 0.05, which is inconsistent with the experiments using I x 102 
pfu/mem brane. 
The titres observed at the final time-point were much the same whether 1 x 102 or 











Table 4.7: Table showing average titres obtained at 0, 24, 48 and 72 h following 
infection of embryonated hens' eggs with I x 104 pfu ofCPY WT. 
Time Number of Number of Titre (pfu/ml) A verage titre 
post- plaques plaques (~fu/ml} 
infection ( dilution multiplied by 
(h) counted) 5 
0 0(0) 0 0 0 
0(0) 0 0 
0(0) 0 0 
24 17 (I x IO-L ) 85 8500 9.50 x 10J 
15 (1 x IO-L ) 75 7500 
25 (1 x 10-L ) 125 12500 
48 102 (I x IO-
q
) 510 5100000 5.12 x 10° 
I 04 (1 x lQ-q) 520 5200000 
101 (1 x 10-'1) 505 5050000 
72 34 (l x 10-) 170 17000000 2.08xI0' 
42 (1 x 10-) 210 21000000 
49 (1 x 10-) 245 24500000 
Table 4.8: Table showing average titres obtained at 0, 24, 48 and 72 h following 
infection of embryonated hens' eggs with I x 104 pfu ofCPY IMP-. 
Time post- Number of Number of Titre (pfu/ml) Average titre 
infection plaques plaques (~fu/ml} 
(h) (dilution multiplied by 
counted) 5 
0 0(0) 0 0 0 
0(0) 0 0 
0(0) 0 0 
24 72 (1 x IO-J ) 360 3600 3.47 x 10-' 
57 (1 x IO- J ) 285 2850 
79 (l x 10- 1) 395 3950 
48 124 (l x IO-J) 620 620000 6.28 x 10) 
129 (l x IO-J) 645 645000 
124 (l x lQ-J) 620 620000 
72 64 (1 x 10-) 320 32000000 3.33 x 10 
62 (1 x 10-) 310 31000000 
74(1 x 10-) 370 37000000 
Fig 4.1-4.4: 4.1: Figure showing the viral titres of CPY WT and CPY IMP-
against time in CY -I monolayers, using a MOl of 2.9 x 10-5 pfulcell. Fig 4.2: 
Figure showing the change in viral titres of CPY WT and CPY IMP- against time 
in CY-I monolayers, using a MOl of2.9 x 10-3 pfu/cell. Fig 4.3: Figure showing 
the change in viral titres of CPY WT and CPY IMP- against time on the chick 
CAM, using I x 102 pfu to infect each membrane. Fig 4.4: Figure showing the 
change in viral titres of CPY WT and CPY IMP- against time on the chick CAM, 
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Table 4.9: Table summarizing the average titres obtained at each time point when CPY WT and CPY IMP- were propagated in CY -I cell 
monolayers or in chorioallantoic membranes, using I x 102 and I x 104 pfu of virus to infect. 
Time post- CY-I CY-I CY-I CY-I Chorioallantoic Chorioallantoic Chorioallantoic Chorioallantoic 
infection monolayers monolayers monolayers mono layers membranes membranes membranes membranes 
(hours) infected infected infected infected infected with I infected with I infected with I infected with I 
with I x 102 with I x 102 withlxl04 with I x 104 X 102 pfu CPY x 102 pfu CPY x 104 pfu CPY x 104 pfu CPY 
pfu CPY pfu CPY pfu CPY pfu CPY WT (titre in IMP- (titre in WT (titre in IMP- (titre in 
WT (titre in IMP- (titre WT (titre in IMP- (titre pfu/ml) pfu/ml) pfu/ml) pfu/ml) 
pfu/ml) in pfu/ml) pfu/ml) in pfu/ml) 
0 5 1.67 1.43 x 10L 1.50 x 10L 0 0 0 0 
6 10 3.33 1.52 x 10L 8.61 X 10 1 
12 10 1.67 1.95 x loj 2.93x1OL 
24 5.85x1OL 4.50 x 10L 2.IOxI0) 5.07x104 2.92 X 104 3.33 X 104 9.50 x 10J 3.47 x loj 
30 3.42 x 10J 4.02 x 10J 4.83 x 10) 9.07x 104 
36 5.27 x 10J 1.53 x 104 6.13 x 10) 5.05 X 10) 
48 4.73 x 104 2.60 X 104 2.85 x 10'" 7.73 X 10) 3.03 X 10 ' 2.82 X 10' 5.12 x 10'" 6.28 x 10) 
60 5.68x104 7.42 X 104 2.65 x 10'" 1.92 x 10'" 












Figures 4.1 and 4.2 show the growth curves for both CYP WT and CPY IMP-
using 1 x 102 and 1 x 104 pfu, respectively, of each virus to infect CY-l 
monolayers. The growth rates of the two viruses were similar in both cases, 
with both viruses showing a steady increase in titre with increasing time up to 48 
h. A student's t test was performed using Excel. Most of the p values returned 
by the programme were greater than 0.05. Thus at a confidence interval of95%, 
one can say that at the time-points that yielded p values greater than 0.05, the 
growth of CPY and CPY IMP- are not statistically different. However, in order 
to get a more precise statistical result (since each of the other growth curves did 
not yield consistent p values at each time point) the growth curves should be 
repeated. In addition, the dilution series should be repeated for greater statistical 
accuracy. 
The final titres obtained when infecting the monolayers with I x 102 pfu of 
CPY WT or CPY IMP- were 2.92 x 105 and 3.33 x 105, respectively. When 
infecting with 1 x 104 of CPY WT or CPY IMP-, titres of 2.13 x J 06 and 1.35 x 
106 were obtained, respectively. Thus only a 1 Jog difference in the final tire 
was seen between using 1 x 102 and 1 x 104 pfu of virus to infect (which is a 2 
log difference). 
In cell culture, there is no immune system present. The IMP of CPY is 
postulated to bind to C3 and C4 of the complement system (since it is a homolog 
of YCP, which binds to these complement components [Kotwal, GJ., et ai, 
1990; McKenzie, et ai, 1992]), thereby inhibiting both the alternative and 
classical pathways of complement activation. The complement system forms 
part of the innate immune system (Parham, P., 2005). As such it is absent from 
cell culture. Therefore, there is no target for IMP in the CY -1 monolayers. 
Thus the fact that there is no difference in the growth curves of the two viruses 
is not surprising. Furthermore, it has been shown that YCP is not a requirement 











completely YCP-deficient are able to replicate in cell culture (Kotwal, GJ., et 
aI, 1990). 
Similarly, growth curves for each virus were generated in embryonated hens' 
eggs. The CAM of each egg was infected with 1 x 102 or I x 104 pfu of either 
CPY WT or CPY IMP'. Figures 4.3 and 4.4 show the growth curves for both 
the wild type and recombinant virus, respectively, at time points ranging from 0 
to 72 h. The majority of p values obtained at each time-point for 1 x 102 
pfu/membrane were greater than 0.05, indicating that at these time-points the 
growth of the two viruses are not statistically different. Using 1 x 104 
pfu/membrane the p values were less than 0.05, suggesting that the growth 
curves may not be the same. However, these experiments should be repeated to 
get statistically significant comparisons. The final titres obtained when infecting 
the membranes with 1 x 102 pfu of CPY WT or CPY IMP- were 5.00 x 107 and 
2.42 x 107, respectively. When infecting 1 x 104 pfu of CPY WT or CPY IMP-, 
titres of2.08 x 107 and 3.33 x 107 were obtained, respectively. Thus, the amount 
of virus used to infect initially did not influence the final titre observed in this 
experiment. 
For both the wild type and the knockout viruses, virus was not detected at 0 h 
post infection of chick CAMs. This phenomenon has been described previously. 
Hahon and Friel (1961) found that when harvesting the chick CAMs 30 minutes 
after infection, up to 90% of the virus was present in the fluid used to wash the 
membranes. In this experiment, each membrane was rinsed twice in PBS before 
extraction of virus. Yirus present in this rinsing fluid was not titrated. This 
probably accounts for the apparent decrease in viral titre at 0 h after infection. 
This is in contrast with the results seen by Esteban and Metz (1973), with 
vaccinia virus infection in cell culture. After a period of only 15 min, viral 
polypeptides were detected as early as 20 min later. In my experiment in cell 
culture a 2 log difference was observed in the amount of virus particles used to 
infect compared to the amount recovered. Perhaps this is due to the fact that 
following adsorption the inoculum is removed from the flask. Thus any virus 
that has not yet entered a cell is lost, and at 0 h, at which point the flask contents 











particles that have gained entry to the cell are detected upon titration. In 
addition, the virus is uncoated upon entry and no longer infectious. This 
probably accounts for the decrease in viral titre immediately following infection. 
When titrating the virus, the inoculum was removed after 1.5 h adsorption. This 
could account for a further reduction in titre. 
In cell culture a I x 104-fold increase in viral titre was seen over 48 h, whereas 
in eggs a I x 107 -fold increase was seen over the same time period. This was 
observed when cell monolayers and CAMs were infected with both 1 x 102 and 
1 x 104 pfu of virus. This indicates that the egg CAM system is a much more 
efficient system for culturing large stocks of virus than the CY -1 monolayer 
system is. 
In the CAM system, it was not known whether there would be a difference 
between the wild type and recombinant viruses in viral growth as the chick 
immune system is only a developing immune system. Here I have shown that 
there does not seem to be a difference between the growth curve of wild type 
cowpox virus and that of the recombinant lacking the IMP. YCP has been 
shown to bind to C4b (Kotwal, GJ, el ai, 1990), thus inhibiting the classical 
pathway of complement, and also to C3b (McKenzie, el ai, 1992), thus 
inhibiting the alternative pathway of complement. The complement system is 
implicated in inflammation through the production of the chemoattractant by-
products, C3a, C4a and C5a (Parham, P., 2005). These bind to receptors on 
mast celis, resulting in the release of vasoactive substances. However, in the 
chick embryo, mast cells are first detected at 15 days after fertilization 
(Crivellato, E., el ai, 2005). In this experiment the chicks were infected at the 
age of 9-1 1 days, and the membranes were thus harvested at 12-14 days. In 
addition to this, the complement system has been found to be present in the 
chick embryo by day 13, however, it is present in low levels (Gabrielsen, A., el 
ai, 1973). Complement levels slowly increase and continue to do so slowly until 
there is a sharp increase in complement activity only 21 days after hatching. 
Since IMP is postulated to bind to C3b and C4b (being a homolog of YCP), it 
would inhibit the formation of the chemotactic by-products, and therefore 











However, one of these systems (mast celJ release of vasoactive products) is not 
yet present and the other (the complement system) is only present at low levels 
in the developing chick. This may explain why IMP has not conferred any 
advantage in the chick CAM system. 
Previous studies have been conducted in which the expression of certain 
vaccinia virus genes have been under the control of different expression 
systems, or where stretches of coding sequences have been deleted from the 
gene of interest. Other studies have attempted to isolate mutant viruses in which 
an open reading frame of interest has been inactivated through the insertion of a 
gpt selection marker. These have revealed proteins that are important in viral 
growth and replication. Examples of these are the I7L gene product (Byrd, 
C.M., and Hruby, D.E., 2005) and the GIL gene product (Ansarah-Sorbrinho, C. 
and Moss, B., 2004). These two proteins are involved in the cleavage of core 
protein precursors and core condensation and the morphogenesis of infectious 
virions. Other proteins that are essential to viral growth are those involved in 
DNA replication, such as the products of A20R, D4R and D5R (Ishii, K and 
Moss, B, 200 1; Upton, c., et ai, 1993; Stuart, D.T., et ai, 1993; Ellison, K.S., et 
ai, 1996; Evans, E., et ai, 1995). These three proteins form part of a DNA 
replication complex, with D4R functioning as a uracil DNA glycosylase. 
Thus it may be that a protein that is not directly involved in the propagation of 
infectious progeny may not be essential for viral growth in cell culture or in ovo. 
However, in the presence of a mature immune system the presence of this gene 
product could confer a growth advantage on the virus. Examples of these 
proteins are listed in table 1 (chapter 1, section 2). The next chapter describes 
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The aim of the experiments discussed in this chapter is to determine the effect of 
IMP on the replication of cowpox virus in a mamma.lian in vivo model. While 
cowpox virus has been shown to have a broad host range (Baxby, D., et ai, 
1994), the true reservoirs of this virus are rodents (Chantrey, J., et ai, 1999). 
Thus, studies using cowpox virus in mice would represent a matched virus:host 
interaction, and the data generated could be extrapolated to other poxvirus:host 
systems. 
Previous studies have only looked at the effects of IMP on cellular infiltration 
and host tissue at the site of infection (Miller, e.G., et ai, 1997). The authors 
found that infection with the virus lacking the IMP resulted in increased tissue 
damage relative to infection with the wild type virus. In addition, they found 
greater haemorrhage of blood vessels and hardening/thickening of tissue 
(induration) at the site of infection. Injection in the footpads of mice with 
recombinant virus resulted in a greater swelling response than that seen in mice 
infected with wi ld type virus (Mi ller, e.G., et ai, 1997). 
Kotwal, GJ., et al (1998) used the connective tissue air pouch model, described 
by Edwards, J.e., et al (1981), to evaluate the difference between the wild type 
and knockout viruses. They found that a lack of IMP resulted in a significant 
influx of mononuclear cells into the site of infection and into the immediately 
surrounding skin. 
Furthermore, Kotwal, GJ., et al (1998) found that infection of C3 knockout 
mice with wild type cowpox virus in the footpads resulted in an increased 
specific swelling response, relative to infection of mice homozygous for C3 
production. This suggests that C3 is important in the pathogenesis of cowpox 
virus. BALB/c mice have low levels of C3 . Thus a more rapid disease 
progression would be expected with this particular strain. This strain of mice 
was chosen for my experiments and a difference in growth characteristics was 











Neither Miller, e.0., e/ al (1997) nor Kotwal, OJ., e/ al (1998) investigated the 
effect of IMP on viral titre. In this study the wild type and knockout virus were 
used to infect mice in an air pouch created on the dorsum and the viral titres 
were determined at various time-points. The wild type virus was expected to 
grow to higher titres than the knockout virus due to its greater ability to evade 











5.2. Materials and Methods 
5.2.1. Evaluation of viral titres using the connective tissue air-pouch 
method 
Animal ethics approval was obtained from the University of Cape Town Animal 
Ethics committee before any animal experimentation was performed. A total of 
117 BALB/c mice were used in this experiment. The mice were divided into 3 
groups of 39. The mice in each group were infected with PBS, CPY WT or 
CPY IMP-. A volume of 1 cm3 of air was injected subcutaneously on the 
dorsum of each mouse using a 29-gauge needle, to create the air pouch. Into 
this air pouch 100 I ..t! of PBS (containing 106 pfu of either CPY WT or CPY 
IMP-, or simply PBS) was injected using a 27-gauge needle. 
The connective tissue underlying the air pouch was collected every second day 
for fourteen days, and thereafter every five days for thirty days. From each 
group (PBS-, CPY WT- and CPY IMP--infected), three mice were used at each 
time point. The mice were euthanized by CO2 asphyxiation. The skin on the 
dorsum was removed by cutting around the air pouch. The connective tissue 
was then removed using a surgical blade and snap-frozen in liquid nitrogen. The 
connective tissue was then stored at -80°C. 
To release the virus from the cells, each connective tissue sample was removed 
from -80°C storage and 2.5 ml trypsin and 2.5 ml PBS was added to it. The 
connective tissue was then homogenized for 10 minutes using an Ultra-Turrax 
T8 homogenizer (Jka Labortechnik). The sample was then successively frozen 
and thawed at -80°C and 37°C, respectively, for 3 cycles. The freeze-thaw 
cycles were followed by sonication (2 cycles of 30 seconds each, with a 30 sec 
gap period in between), using a Yirsonic 100 (YirTis). 
The samples were titrated on BS-C-I cells as follows: 6-well plates were seeded 
with BS-C-l cells. The cells were maintained in DMEM supplemented with 
10% FCS, at 37°C. Once the monolayers in each well were confluent, the 











was added. To the first well, I III of the connective tissue homogenate was 
added. Thus, this was a I: 1000 dilution of the homogenate. A Guilson pipette 
was used to mix the medium and virus thoroughly. From the first well, 100 III 
was transferred to the second welJ, making a 1: I 0 000 dilution of the 
homogenate. This was repeated until 5 wells were inoculated with 1: 103, I: 104, 
1:105, 1:106 and 1:107 dilutions of the homogenate. The last well was left 
uninfected as a control. The plate was then incubated at 37°C for 2 h, after 
which 1 ml of the medium removed from the plate before infection was added to 
each well. Thus, the final volume in each well was 2 ml. The plate was then 
incubated at 37°C for 72 h. Thereafter the plate was removed from the 
incubator, the medium removed and the cells stained with crystal violet (10% 
crystal violet solution [v/v], Merck, New Jersey, USA; 10% formaldehyde 
[v/v]). After 15-20 min the stain was removed and the plates were allowed to 
dry overnight. 
No plaques were visible in any of the wells of the 6-well plate. Thus, following 
the mechanical homogenization and titration, each sample was then manually 
homogenized in 5 ml Mcilvain's buffer, using Dounce homogenizers. Lysis of 
the connective tissue was brought about by 80-100 strokes of the homogenizer 
probe. Each sample was then taken through 3 freeze-thaw cycles, and following 
this 50 III trypsin was added. The sample was incubated with the trypsin for 15 
minutes at 3rc. The samples were sonicated for 2 cycles of30 sec each, with a 
30 sec gap period in between. 
Each sample was titrated again on BS-C-I cells as outl ined above. 
5.2.2. Extraction of DNA from connective tissue samples 
Total DNA was extracted from the connective tissue samples. To 500 III of 
sample,S III of a 10 mg/m! proteinase K solution was added. Each sample was 
then placed at 56°C for 15 min. To inactivate the proteinase K the samples were 
incubated at 95°C for 10 min. To precipitate the DNA, 50 III of ice cold sodium 
acetate (3M, pH 8) and 500 III ice cold isopropanol was added to each sample. 











20 times. Samples were centrifuged at 14 000 rpm (Beckman Microfuge E). 
The supernatant was removed and the pellets were washed by addition of 10 )ll 
of 70% ethanol and centrifugation at 5000 rpm. Following washing the pellets 
were allowed to air dry and then resuspended in 30 )ll H20. 
5.2.3. PCR to confirm the presence of the BALB/c mouse DNA in the 
connective tissue samples 
To determine whether BALB/c mouse DNA was present in the connective tissue 
samples, the forward primer exon 7 forward 1 (5' TGA CCT ACA AGG AAC 
CCA GGC 3') and reverse primer exon 8 reverse (5' CTC GGC GCA CTG 
ACC CAT CT 3 ') were used. Exon 7 forward binds within exon 7 and exon 8 
reverse binds within exon 8 of the gene encoding ILARa in BALB/c mice, 
amplifying a stretch of 600 bp of the gene. The primers were donated by Prof. 
F. Brombacher's research group (Division of Immunology, Institute of 
Infectious Diseases and Molecular Medicine, UCT). For each reaction, 0.25 )lM 
of each primer, 0.5U TaqDNA Polymerase, Ix PCR buffer, 0.2 mM dNTP 
mixture and 1.5 mM MgCb were used. The PCR conditions used were as 
follows: 94°C for 1 min; 40 cycles of 94°C for 30 s, 58°C for 20 s, and noc for 
1 min; and noc for 5 min. Purified BALB/c mouse DNA, also obtained from 
Prof. F. Brombacher's research group, was used as a positive control. 
The PCR products were subjected to agarose gel electrophoresis as outlined in 
chapter 3. 
5.2.4. PCR to confirm the presence of the viral DNA in the connective 
tissue samples 
The primers IMP PCR FWD and IMP PCR REV were used to determine 
whether CPV WT or CPV IMP- DNA was present in the connective tissue 
samples. For each reaction, 50 pmol/)ll of each primer, 2.5U of GoTaq DNA 
polymerase, Ix PCR buffer, 1.5 mM MgCh and 0.2 mM dNTP mixture 
(Prom ega, Wisconson, USA) were used. The PCR conditions were as follows: 











min; and noc for 10 min. Purified CPV WT and CPV IMP- DNA samples 
were used as positive controls. 
Following amplification, the PCR products were subjected to electrophoresis on 
a 1% agarose gel as outlined in chapter 3. 
5.2.5. PCR to confirm the presence of the gDt insert in the connective 
tissue samples infected with CPV IMP-
PCR using the primers IMP PCR FWD and IMP PCR REV did not yield 
positive results for all the of the samples infected with CPV IMP-. The expected 
fragment was 3.6 kb for CPV IMP-, as compared to 1.4 kb for CPV WT. It is 
possible that this fragment is too large to amplify efficiently and so primers were 
designed which bind within the coding sequence of gpt (which is part of the 3.6 
kb fragment). The forward primer GPT FWD (5' CCT GGG ACA TGT TGC 
AGA TCC 3') and reverse primer GPT REV (5' TAT CCC ACG GCT GTT 
CAA TCC 3') were used. A product of 398 bp was expected to be amplified 
using these primers. For each reaction, 50 pmol/I.d of each primer, 2.5U of 
TaqDNA polymerase, 1 x PCR buffer, 1.5 mM MgCb and 0.2 mM dNTP 
mixture (Promega, Wisconsin, USA) were used. The PCR conditions were as 
follows: 94°C for 1 min; 40 cycles of 94°C for 30 s, 59°C for 20 s, and noc for 
1 min; and noc for 5 min. As a positive control, purified DNA from the 
plasmid pGPT07114, in which gpt is inserted (Boyle, D.B. and Coupar, E.H., 
1988), was used. The plasmid was obtained from Dr. Nicola Douglass, donated 












1 agaataccac tttatcccgc gtcagggaga ggcagtgcgt 
41 aaaaagacgc ggactcatgt gaaatactgg tttttagtgc 
81 gccagatctc tataatctcg tttcccctcg 
121 aacacttttt aagccgtaga 
161 aaaatacatc 
201 cgtaaactcg caagccgact gatgccttct 
241 gaacaatgga aaggcattat tgccgtaagc cgtggcggtc 
281 tggtaccggg tgcgttactg gcgcgtgaac tgggtattcg 
321 tcatgtcgat accgtttgta tttccagcta cgatcacgac 
361 aaccagcgcg agcttaaagt gctgaaacgc gcagaaggcg 
401 atggcgaagg cttcatcgtt attgatgacc tggtggatac 
441 cggtggtact gcggttgcga ttcgtgaaat gtatccaaaa 
481 gcgcactttg cgcaaaaccg gctggtcgtc 
521 cgct tgatatcc cgcaagatac 
561 c gggcgt cgtattcgtc 
601 ccgccaatct ccggtcgcta a 
Fig 5.1: Figure showing the coding sequence of gpl. The binding sites 
for the forward primer, GPT FWD, and the reverse primer, GPT REV, 












5.3.1. Evaluation of viral tit res using the connective tissue air-pouch 
method 
Following titration on BS-C-J cells, no plaques were seen and so the samples 
were manually homogenized and re-titrated. No plaques were seen after the 
second round of homogenization and titration. It was decided to perform PCR 
to investigate whether viral DNA was present in the samples as the virus may 
have been inactivated during sample preparation. 
5.3.2. peR to confirm the presence of viral and cellular DNA in the 
connective tissue samples 
5.3.2.1. peR to detect BALB/c mouse DNA 
As a control to determine whether DNA was present in the samples, a PCR 
experiment was set up to amplify BALB/c mouse DNA. The DNA purified 
from the samples was used as template to amplify a 600 bp region in the gene 
encoding IL-4Ru. This was done primarily to ensure that DNA had been 
extracted successfully from each sample and that PCR inhibitors were not 
present in the samples. Figures 5.2, 5.3 and 5.4 show the PCR products after 
subjection to agarose gel electrophoresis. 
All the connective tissue samples yielded a product for the IL-4Ru gene, except 
for I (fig 5.3, lane 14). This corresponds to the CPY WT-infected connective 
tissue, harvested 6 days post-infection. CPY WT DNA was recovered from this 
sample (fig. 5.6, lane 14). 
5.3.2.2. peR to detect viral DNA 
To determine whether or not viral DNA was present, primers were designed to 
bind to regions flanking the gene encoding IMP. Thus, for samples in which 











with CPY IMP-, a product of 3326 bp was expected (refer to chapter 3, section 





PBS CPV WT CPV IMP- PBS CPV WT CPV IMP-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 151617 18 19 
Fig. 5.2: PCR products obtained using primers that amplify 600 bp of 
the IL-4Ra gene, following agarose gel electrophoresis. Lane 1 
shows the molecular weight marker. Lanes 2-10 show products from 
samples harvested 2 days post-infection. Lanes 11-20 show products 
from samples harvested 10 days post-infection. Product was yielded 
from all samples. 
PBS CPV WT CPV IMP- PBS CPV WT CPV IMP-
12345 67 89101112131415161718192021 
Fig. 5.3: PCR products obtained using primers designed to amplify 600 bp of the 
IL-4Ra gene. Lane 1 shows the molecular weight marker. Lanes 2-10 show 
product from samples harvested 4 days post-infection. Lanes 11-19 show 
product from samples harvested 6 days post-infection. Lane 20 shows the 
negative control. Lane 21 shows the positive control (purified BALB/c mouse 











PBS CPVWT CPV IMP 
710 
492 
1 2 3 4 5 6 7 8 9 10 
Fig. 5.4: PCR products obtained using primers designed to amplify 600 bp of 
the IL-4Ra gene. Lane 1 shows the molecular weight marker. Lanes 2-10 
show product from samples harvested 8 days post-infection. 
Figures 5.5, 5.6 and 5.7 show the results of this experiment. 
For the first time point (2 days post-infection), only 2 of the 3 wild type samples 
yielded products of the correct size (fig. 5.5, lanes 7 and 9), while for the knock 
out samples no products were seen (fig. 5.5, lanes 10-12). 
Four days post-infection, 2 of the 3 wild type samples yielded product (fig. 5.6, 
lanes 5 and 7), and 1 knock out sample yielded product (fig. 5.6, lane 10). At 
the next time point (6 days post-infection) all the wild type samples yielded a 
product (fig. 5.6, lanes 14-16). None of the knock out samples yielded products 
of the correct size. However in lane 18 of fig. 5.6, a band of 1397 bp was seen, 
indicating possible contamination of this sample, since this band size is expected 
from the wild type virus. A later experiment (fig. 5.8, lane 11) shows CPY IMP' 
viral DNA is present in this sample. 
Eight and 10 days post-infection, all the wi Id type samples yielded a product 
(fig. 5.7, lanes 5-7 and 14-16, respectively) . One of the 3 (fig. 5.7, lane 9) and 2 











infection, respectively, yielded product of the correct size. Table 5 shows the 
number of positive PCR products found at the different times when connective 
tissue was harvested. 
Table 5: Table showing the number of samples out of a total of 3 in each test 
group that yielded a positive PCR result, using the primers IMP PCR FWD and 
IMP PCR REY. 
Days post CPVWT CPV IMP-
infection 
2 2 0 
4 2 1 
6 3 0 
8 3 1 
10 3 2 
PBS CPVWT CPV IMP-
3639 __ 
1482 --
1 2 3 4 5 6 7 8 9 10 11 12 
Fig 5.5: PCR products following electrophoresis on a 1% agarose gel. 1: 
molecular weight marker; 2: Purified CPY WT DNA; 3: Purified CPY IMP- DNA; 
4-6: PBS samples; 7-9: CPY WT samples; 10-12: CPY IMP- samples. Samples in 











PBS CPV WT CPV IMP- PBS CPV WT CPV IMP-
3639 
1482 
2 3 4 5 6 7 8 9 10 111213 14 15 16 17 18 19 
Fig 5.6: PCR products following electrophoresis on a 1 % agarose gel. 1: 
molecular weight marker; 2-4: PBS samples; 5-7: CPY WT samples; 8-10: 
CPY IMP-samples. Samples in lanes 2-10 were harvested 4 days post-
infection. 11-13: PBS samples; 14-16: CPY WT samples; 17-19: CPY IMP-
samples. Samples in lanes 1 J -19 were harvested 6 days post-infection. 
PBS CPV WT CPV IMp· PBS CPVWT CPV IMP-
3639 
1482 
1 2 3 4 5 6 7 8 9 10 111213 14 15 16171819 
Fig 5.7: PCR products following electrophoresis on a 1% agarose gel. I: molecular 
weight marker; 2-4: PBS samples; 5-7: CPY WT samples; 8-10: CPY IMP·samples. 
Samples in lanes 2-10 were harvested 8 days post-infection. 11-13: PBS samples; 
14-16: CPY WT samples; 17-19: CPY IMp· samples. Samples in lanes 11-19 were 













5.3.3. PCR to confirm the presence of the get insert in the connective 
tissue samples infected with CPV IMP-
The IMP prtmers were designed to amplify a large product (3.639 bp) . 
Therefore a possible reason for the negative results seen for the CPY IMP--
infected samples using the IMP primers is that the product size is too large. In 
PCR, smaller products are amplified more readily than larger ones, and so 
primers were designed to amplify a smaller DNA sequence. 
Fig. 5.8 shows the result of the PCR performed to amplify gpt from DNA 
isolated from samples infected with CPY IMP-. Lane 3 shows the positive 
control. All the other samples, except for those in lanes 13 and 15 (CPY IMP-, 8 
days post-infection) yielded products. The samples used in lanes 13 and 15 did 
not yield a product when the primers IMP PCR FWD and IMP PCR REY were 
used (fig.5 .7, lanes 8 and 10). 
2 4 6 8 10 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Fig. 5.8: Figure showing PCR products which were subjected to 
electrophoresis. The primers GPT FWD and GPT REY were used to 
amplify a 398 bp fragment of the coding sequence. Lane 1: molecular 
weight marker; lane 2: negative control; lane 3: positive control; lanes 4-6: 
connective tissue samples harvested 2 days post-infection; lanes 7-9: 
connective tissue samples harvested 4 days post-infection; lanes 10-12: 
connective tissue samples harvested 6 days post-infection; lanes 13-15: 
connective tissue samples harvested 8 days post-infection; lanes 16-18: 
connective tissue samples harvested 10 days post-infection. All samples 
were inoculated with CPY IMP-. Numbers above gel indicate days post-











Connective tissue samples which were expected to be negative for gpt (PBS-
and CPV WT-infected samples) were negative for the 398 bp product after PCR 
with the GPT FWD and GPT REV primers, shown in fig. 5.9. 
710 
492 
1 2 3 4 
PBS CPVWT 
5 6 7 8 9 
Fig. 5.9: PCR products after electrophoresis on an agarose gel. The 
GPT FWD and GPT REV primers were used. Lane I: molecular weight 
marker; lane 2: negative control; lane 3: positive control; lanes 4-6: PBS 












In order to evaluate the role IMP cowpox an in vivo 
modeJ, the pouch model was used in BALB/c mice. In the air 
pouch model, 1 
air pocket 
of air is 
is 
into the dorsum of the animal to create an 
injected into air IJV,,,.n. ... ' •• 
were for this experiment as they have low 
more disease progression would be (Kotwal, 
of C3, and thus a 
et ai, 1998). 
were 3 groups 1 group infected with 
CPV IMP- and, and 1 group mock-infected with 
WT, 1 group with 
each time-point, 3 
mice each group were group size was not increased as 
previous experiments have shown that an increased number of per 
group does not improve the standard deviation (Miller, et] 995). 
Connective samples collected from mice were mechanically 
by titration on BS-C-l cell No plaques 
were seen and so the were subjected to a second round of 
homogenization. Each sampJe was manually homogenized and then 7'"_1'11-7,,,1",,.11 
HnU,p'\fpr this did not any plaques. 
was unexpected as mice are known to support the replication of 
cowpox virus. DNA been shown to at the site infection following 
inoculation with a candidate (Hanke, T. et aI, 2002), up to 72 days 
are 
In were 10 days post-
the "",;:",",11',,,, 
the virus was eliminated the mouse immune "·,,"ltPWl 
culture 
or the virus was 
As seen in chapter 4, the collection/homogenization oroces:s. 
tiittpt',pn.'p between amount of virus used as inoculum and 
.. ",,,.,.,.,,,,,..,,,, .. in the titration. Thus the technique may also not have 
been enough. To whether DNA was present in 
was performed. primers IMP FWD IMP 
REV were to bind to upstream downstream, 










5 and figs. 5.5, to an 
.n£>lrF""'OF" in CPV WT viral DNA as increases. It cannot be that 
grows better than IMP-, as the smaller band (1.4 kbp) would 
more readily than the band (3.4 kbp). For this reason, nr.mpf'(: 
were designed to amplify a "u.~u,...,. DNA fragment in CPV . Primers 
"'''''''aln", ... to amplifY a 398 bp the gpt coding sequence were 
seen in fig 5.8, all except 2 sanlpll~S a PCR 
band The 2 negative """'V""''' did not yield a product 
PCR FWD and IMP were used either (fig 5.7, 
A likely reason for the in this sample is a 
in the PCR reaction. 
FWD 
it is that there is 
clear increase or decrease 
primers with CPV 
n .. "·..,p,,,!" in the samples. 




is not a 
time point 
to last. From the one cannot say whether or not 
two viruses. TT"",·""..",," in viral replication ... "",.,,,,,,,,, ..... 
IS a 
virus was not picked up by the plaque assay, it is possible that virus was 
,""<>I',"nl<>T.,,., during the of or homogenization, and that the DNA 
PCR is that Alternatively, the was not 
as an as of the was not 
determined, so the relative amounts could not 
It was thought that this murine model yield results that 
indicated whether or not IMP confers any advantage to virus with regard to 
viral replication in an animal model. However, it is my OOllllC)fl that the route of 
"""J"'-'" employed was not optimal for determination viral titres, and so the 
pouch model was to look at 
infection (Smith, Kotwal, G.J., 2002), 
model to use when one wants to determine viral at 
at the site 











VIruS has been 
(Morishima, 
nIl1l1sterc:(1 intravenously 
from the when administered 




accurate quantitative result Due to time 
experimentation could not performed. 
or intraperitoneally (N. 












this project can 
IMP that was generated 
one. This was 
Ramachandran plots generated for both 
and IMP from the computed structure. 
functions ofIMP and VCP are probably conserved. 
the CAM model was shown to support 
in 3 sec1tJOnlS. Firstly, 




rrrr.urlh of the deletion 
mutant virus as efficiently as that of the wild type pocks produced 
on the chorioallantoic membrane were equal and 
were in colour. This indicates that IMP is not implicated in the 
The plaques produced on CV-l 
were identical in size and mClroin010g 
growth curves of both 
in both cell culture and in ovo. In 
.",,... .. ,,,,,,,,,,,11 steadily up to 48 h, with a 4 log 
ovo was a 6-7 log increase in titre in 
JUl\J'-'''"v .... virus were 
rates 
CAM system was found to be much more ""'Ln.w,", .. > 
than cell culture, as a I x 107 -fold increase is seen 
by a plateau. 
culturing poxvirus 
in 48 h, compared to 
same time-period. a 1 x 104-fold increase seen in cell monolayers over 
statistical analysis (student'S t test) 
was a significant difference between 
some instances it was the wild 
in others it was the knock out 
result each growth curve be 
that at certain time-
amounts of CPV WT and 
virus that had grown to a 
..... """","'''''t''' .. ,, and equipment. Thus, at one cannot 
obtain a more 
using the same 
with certainty 











The mouse model employed was not suitable 
viral growth in vivo. The presence ofthe 
virus a tTrr,,",'n advantage by inhibition 
a quantitative comparison of 
expected to give 
Dlelmelru system. I was 
thp'rptnrp eXIJec:tmg to see a the ,., .. "',,,, ..... CPV compared to 
CPV 
more suitable for or""'''TM of WT 
IMP- have used mention 
in section However, animal approval had not been obtained for 
enough additional mice to conduct another BALB/c mouse experiment. In 
addition, my supervisor, Kotwal, suddenly and the 
experiments could not 
complete study, the 2 viruses should be compared growth in vivo in 
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